Go to Home

Link | Japanese

Papers [English]


2018年
1. Takahashi Y, Ota H, Omura K, Dendo Y, Otani K, Matsuura T, Kitami M, Seiji K, Tezuka Y, Nezu M, Ono Y, Morimoto R, Satoh F, Takase K: Image quality and radiation dose of low-tube-voltage CT with reduced contrast media for right adrenal vein imaging. Eur J Radiol 98:150-157, 2018
2. Aoki S, Saito-Hakoda A, Yoshikawa T, Shimizu K, Kisu K, Suzuki S, Takagi K, Mizumoto S, Yamada S, van Kuppevelt TH, Yokoyama A, Matsusaka T, Sato H, Ito S, Sugawara A: The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion. Nephrol Dial Transplant. 33(1):26-33, 2018
3. Narumi K, Mishima E, Akiyama Y, Matsuhashi T, Nakamichi T, Kisu K, Nishiyama S, Ikenouchi H, Kikuchi A, Izumi R, Miyazaki M, Abe T, Sato H, Ito S: Focal Segmental Glomerulosclerosis Associated with Chronic Progressive External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation. Nephron. 138(3):243-248, 2018
4. Oba-Yabana I, Mori T, Takahashi C, Hirose T, Ohsaki Y, Kinugasa S, Muroya Y, Sato E, Nguyen G, Piedagnel R, Ronco PM, Totsune K, Ito S: Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells. Sci Rep. 8(1):2648, 2018
5. Kashihara N, Nangaku M, Ito S, Nishiyama A, Harris D: The Sendai declaration for the eradication of kidney disease. Clin Exp Nephrol. 22(1):1-2, 2018
6. Nakayama M, Itami N, Suzuki H, Hamada H, Yamamoto R, Tsunoda K, Osaka N, Nakano H, Maruyama Y, Kabayama S, Nakazawa R, Miyazaki M, Ito S: Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study. Sci Rep.8(1):254, 2018
7. Narumi K, Sato E, Hirose T, Yamamoto T, Nakamichi T, Miyazaki M, Sato H, Ito S: (Pro)renin receptor is involved in mesangial fibrosis and matrix expansion. Sci Rep. 8(1):16, 2018
8. Oe Y, Ko M, Fushima T, Sato E, Karumanchi SA, Sato H, Sugawara J, Ito S, Takahashi N: Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase. Sci Rep. 8(1):102, 2018
9. Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, Rizzoni D, Rossignol P, Ruilope LM, van den Meiracker AH, Ito S, Hasebe N, Webb DJ: Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension. J Hypertens. 36(3):462-471, 2018
10. Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, Rizzoni D, Rossignol P, Ruilope LM, van den Meiracker AH, Ito S, Hasebe N, Webb DJ: Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension. J Hypertens. 36(3):451-461, 2018
11. Morimoto R, Omata K, Ito S, Satoh F: Progress in the Management of Primary Aldosteronism; Am J Hypertens 31(5): 522-531, 2018.
12. Iwai T, Miyazaki M, Yamada G, Nakayama M, Yamamoto T, Satoh M, Sato H, Ito S: Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Clin Exp Nephrol. 22(2); 328-336, 2018
13. Sato E, Wang AY, Satoh M, Nishikiori Y, Oba-Yabana I, Yoshida M, Sato H, Ito S, Hida W, Mori T: Urinary angiotensinogen excretion level is associated with elevated blood pressure in the normotensive general population. Am J Hypertens. 31(6):742-749, 2018
14. Morimoto R, Omata K, Ito S, Satoh F: Progress in the Management of Primary Aldosteronism. Am J Hypertens. 31(5); 522-531, 2018
15. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators: Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 41(6):1275-1284, 2018
16. Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J: Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 93(6):1442-1451, 2018
17. Mao YH, Xu LN, Weng QH, Li XY, Zhao B, Nie JJ, Hu JH, Zhang LQ, Chen Z, Zuo MZ, Ito S, Cai JP: The Ratio of Plasma and Urinary 8-oxo-Gsn Could Be a Novel Evaluation Index for Patients with Chronic Kidney Disease. Oxid Med Cell Longev. 2018 Jan 17;2018:4237812. doi: 10.1155/2018/4237812. eCollection 2018.
18. Mishima E, Fukuda S, Kanemitsu Y, Saigusa D, Mukawa C, Asaji K, Matsumoto Y, Tsukamoto H, Tachikawa T, Tsukimi T, Fukuda NN, Ho HJ, Kikuchi K, Suzuki C, Nanto F, Suzuki T, Ito S, Soga T, Tomioka Y, Abe T: Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model. Am J Physiol Renal Physiol. 2017 Nov 22:ajprenal003142017. doi: 10.1152/ajprenal.00314.2017. [Epub ahead of print]
19. Mishima E, Fukuda S, Kanemitsu Y, Saigusa D, Mukawa C, Asaji K, Matsumoto Y, Tsukamoto H, Tachikawa T, Tsukimi T, Fukuda NN, Ho HJ, Kikuchi K, Suzuki C, Nanto F, Suzuki T, Ito S, Soga T, Tomioka Y, Abe T: Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model; Am J Physiol Renal Physiol 315(4): F824-F833, 2018.
20. Ogawa S, Shimizu M, Nako K, Okamura M, Ito S: Decreased Glycaemia with Renal Failure in Diabetes Betides in Relation to the Change in Renal Glutamate Metabolism; Journal of Clinical & Experimental Nephrology 3(1): 55, 2018.
21. Yamazaki Y, Omata K, Tezuka Y, Ono Y, Morimoto R, Adachi Y, Ise K, Nakamura Y, Gomez-Sanchez CE, Shibahara Y, Kitamoto T, Nishikawa T, Ito S, Satoh F, Sasano H: Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma; Hypertension 72(3): 632-640, 2018.
22. Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, Anand SK, Guo Z, Stowasser M, Sasano H, Tomlins SA, Rainey WE: Cellular and Genetic Causes of Idiopathic Hyperaldosteronism; Hypertension 72(4): 874-880, 2018.
23. Mishima E, Suzuki T, Takeuchi Y, Seiji K, Fukuhara N, Takase K, Harigae H, Abe T, Ito S: Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review; J Clin Hypertens (Greenwich) 20(4): 798-804, 2018.
24. Nezu M, Kudo M, Morimoto R, Ono Y, Omata K, Tezuka Y, Igarashi Y, Hitachi S, Takase K, Ito S, Satoh F: Effects of surgical treatment for acromegaly on knee MRI structural features; Endocr J 65(10): 991-999, 2018.
25. Mishima E, Umezawa S, Suzuki T, Fujimura M, Abe M, Hashimoto J, Abe T, Ito S: Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians; Clin Exp Nephrol 22(6): 1294-1299, 2018.
26. Shimada S, Hirose T, Takahashi C, Sato E, Kinugasa S, Ohsaki Y, Kisu K, Sato H, Ito S, Mori T: Pathophysiological and molecular mechanisms involved in renal congestion in a novel rat model; Sci Rep 8(1): 16808, 2018.
27. Eguchi K, Miyashita H, Takenaka T, Tabara Y, Tomiyama H, Dohi Y, Hashimoto J, Ohkubo T, Ohta Y, Hirooka Y, Kohara K, Ito S, Kawano Y, Sunagawa K, Suzuki H, Imai Y, Kario K, Takazawa K, Yamashina A, Shimada K; ABC-J II Investigator Group: High central blood pressure is associated with incident cardiovascular events in treated hypertensives: the ABC-J II Study; Hypertens Res 41(11): 947-956, 2018.
28. Nakayama M, Watanabe K, Hayashi Y, Terawaki H, Zhu WJ, Kabayama S, Ito S: Translational Research of Peritoneal Dialysis Solution with Dissolved Molecular Hydrogen; Contrib Nephrol 196: 162-170, 2018.
29. Ogawa S, Nako K, Ito S: Effects of sodium-glucose cotransporter 2 inhibitors on hypoglycaemia in brittle diabetic patients with decreased endogenous insulin secretion; Endocrinol Diab Metab 2018; e00044, 2018.
30. Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S; JSH Future Plan Working Group and Executive Board Members: The Japanese Society of Hypertension-Digest of plan for the future; Hypertens Res. 41(12): 989-990, 2018
31. Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators: Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial; Am J Kidney Dis 72(6): 798-810, 2018
32. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators: Achieving LDL-C target levels less than 70 mg/dL may provide extra cardiovascular protection in high-risk patients: exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients With Hypercholesterolemia and Diabetic Retinopathy Study; Diabetes Obes Metab. 2018 Nov 4. [Epub ahead of print]
33. Wang A, Hirose T, Ohsaki Y, Takahashi C, Sato E, Oba-Yabana I, Kinugasa S, Muroya Y, Ito S, Mori T: Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats; Clin Exp Nephrol. 2018 Nov 13. [Epub ahead of print]
34. Shimada S, Nakamichi T, Yamada G, Narumi K, Usubuchi H, Yamamoto T, Ichikawa S, Fukuhara N, Miyazaki M, Harigae H, Sato H, Ito S: Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphoma; CEN Case Rep. 2018 May 15 [Epub ahead of print]
35. Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium and CKD Epidemiology Collaboration: Change in albuminuria and subsequent risk of end-stage kidney disease: an individual level consortium meta-analysis of observational studies; Lancet (In Press)
36. Ito S, Kagawa T, Saiki T, Shimizu K, Kuroda S, Sano Y, Umeda Y: Efficacy and Safety of Imarikiren in Patients With Type 2 Diabetes and Microalbuminuria: A Randomized Controlled Trial; Clin J Am Soc Nephrol (In Press)

- Top | Home -

2017年
1. Omura K, Ota H, Takahashi Y, Matsuura T, Seiji K, Arai Y, Morimoto R, Satoh F, Takase K: Anatomical Variations of the Right Adrenal Vein: Concordance Between Multidetector Computed Tomography and Catheter Venography. Hypertension 69(3); 428-434, 2017
2. Mori T, Osaki Y, Oba-Yabana I, Ito S: Diuretic Usage for Protection against End-Organ Damage in Liver Cirrhosis and Heart Failure. Hepatol Res. 47(1); 11-22, 2017
3. Hayashi S, Oe Y, Fushima T, Sato E, Sato H, Ito S, Takahashi N: Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice. Biochem Biophys Res Commun. 483(1):547-552, 2017
4. Fushima T, Sekimoto A, Oe Y, Sato E, Ito S, Sato H, Takahashi N: Nicotinamide ameliorates a preeclampsia-like condition in mice with reduced uterine perfusion pressure. Am J Physiol Renal Physiol. 312(2):F366-F372, 2017
5. Nezu M, Souma T, Yu L, Suzuki T, Saigusa D, Ito S, Suzuki N, Yamamoto M: Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression. Kidney Int 91(2):387-401, 2017
6. Saito A, Kimura T, Takeuchi Y, Matsuda K, Fukami H, Sato H, Iwakura Y, Sato H, Nagasawa T: A case of rapid progression of Fabry nephropathy with remarkable glomerulomegaly: a case report and mini literature review of weak response to enzyme replacement therapy (ERT). Renal Replacement Therapy 2017(Open Access)
7. Suzuki T, Seki S, Hiramoto K, Naganuma E, Kobayashi EH, Yamaoka A, Baird L, Takahashi N, Sato H, Yamamoto M: Nat Commun 8:14577, 2017
8. Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, Morimoto R,Nozawa Y, Gomez-Sanchez CE, Tomlins SA, Rainey WE, Ito S, Satoh F, Sasano H:Histopathological classification of cross-sectional image negativehyperaldosteronism. J Clin Endocrinol Metab.102; 1182-1192, 2017
9. Ogawa S, Takiguchi J, Shimizu M, Nako K, Okamura M, Kinouchi Y, Ito S: The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabetics. Clin Exp Nephrol. 2017 Mar 22. doi: 10.1007/s10157-017-1401-1. [Epub ahead of print]
10. Chang CH, Hu YH, Tsai YC, Wu CH, Wang SM, Lin LY, Lin YH, Satoh F,Wu KD, Wu VC: Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.Oncotarget 8(18):29984-29995, 2017
11. Shima H, Sasaki K, Suzuki T, Mukawa C, Obara T, Oba Y, Matsuo A, Kobayashi T, Mishima E, Watanabe S, Akiyama Y, Kikuchi K, Matsuhashi T, Oikawa Y, Nanto F, Akiyama Y, Ho HJ, Suzuki C, Saigusa D, Masamune A, Tomioka Y, Masaki T, Ito S, Hayashi KI, Abe T: A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways. Sci Rep.7(1):1884, 2017
12. Schiffrin EL, Calhoun DA, Flack JM, Ito S, Webb RC: Update From the Editors to Our Readers. Am J Hypertens 30(1):1-2, 2017
13. Satoh F, Sasano H, Yamazaki Y, Ito S: Aldosterone-Producing Adenomas: Genotypes and Phenotypes. Hypertension 70(1):38-41, 2017
14. Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, Arai T, Gomez-Sanchez CE, Sasano H, Ito S, Satoh F: Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay. Hypertension. 2017 Jun 26. pii: HYPERTENSIONAHA.117.09078. doi: 10.1161/HYPERTENSIONAHA.117.09078. [Epub ahead of print]
15. Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017 May 30. pii: S2213-8587(17)30135-3. doi: 10.1016/S2213-8587(17)30135-3. [Epub ahead of print]

- Top | Home -

2016年
1. Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, Takase K, Seiji K, Ishidoya S, Arai Y, Funamizu Y, Miki T, Nakamura Y, Sasano H, Satoh F: Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism. Hypertension 67(3):654-60, 2016.
2. Harms PW, Hovelson DH, Cani AK, Omata K, Haller MJ, Wang ML, Arps D, Patel RM, Fullen DR, Wang M, Siddiqui J, Andea A, Tomlins SA: Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations. Hum Pathol 51:25-31, 2016
3. Monticone S, Satoh F, Dietz AS, Goupil R, Lang K, Pizzolo F, Gordon RD, Morimoto R, Reincke M, Stowasser M, Mulatero P: Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism. Hypertension. 67(1): 146-152, 2016
4. Nakamura Y, Kitada M, Satoh F, Maekawa T, Morimoto R, Yamazaki Y, Ise K, Gomez-Sanchez CE, Ito S, Arai Y, Dezawa M, Sasano H: Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17. Mol Cell Endocrinol. 422; 57-63, 2016
5. Liao CW, Lin LY, Hung CS, Lin YT, Chang YY, Wang SM, Wu VC, Wu KD, Ho YL, Satoh F, Lin YH: Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients. Sci Rep.6:20862, 2016
6. Souma T, Nezu M, Nakano D, Yamazaki S, Hirano I, Sekine H, Dan T, Takeda K,Fong GH, Nishiyama A, Ito S, Miyata T, Yamamoto M, Suzuki N: Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling. J Am Soc Nephrol. 27(2); 428-438, 2016
7. Ota H, Seiji K, Kawabata M, Satani N, Omata K, Ono Y, Iwakura Y, Morimoto R, Matsuura T, Kudo M, Tominaga J, Satoh F, Ito S, Takase K: Dynamic multidetector CT and non-contrast-enhanced MR for right adrenal vein imaging: comparison with catheter venography in adrenal venous sampling. Eur Radiol. 26(3); 622-630, 2016
8. Satani N, Ota H, Seiji K, Morimoto R, Kudo M, Iwakura Y, Ono Y, Nezu M, Omata K, Ito S, Satoh F, Takase K: Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization. Radiology. 271(1); 265-274, 2016
9. Imai E, Ito S, Haneda M, Harada A, Kobayashi F, Yamasaki T, Makino H, Chan JC: Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure). Nephrol Dial Transplant. 31(3); 447-454, 2016
10. Morimoto R, Satani N, Iwakura Y, Ono Y, Kudo M, Nezu M, Omata K, Tezuka Y, Seiji K, Ota H, Kawasaki Y, Ishidoya S, Nakamura Y, Arai Y, Takase K, Sasano H, Ito S, Satoh F: A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery. J Hum Hypertens. 30(6); 379-385, 2016
11. Mishima E, Hashimoto J, Akiyama Y, Shima H, Seiji K, Takase K, Abe T, Ito S: Impact of Small Renal Ischema in Hypertension Developmemt: Renovascular Hypertension Caused by Small Branch Artery Stenosis(Case Report); J Clin Hypertens. 18(3); 248-249, 2016
12. Mishima E, Kikuchi K, Ota H, Akiyama Y, Suzuki T, Seiji K, Hashimoto J, Takase K, Abe T, Ito S: Detection of Segmental Renal Ischemia by Diffusion-Weighted Magnetic Resonance Imaging: Clinical Utility for Diagnosis of Renovascular Hypertension. J Clin Hypertens (Greenwich).18(4); 364-365, 2016
13. Sato E, Mori T, Satoh M, Fujiwara M, Nakamichi Y, Oba I, Ogawa S, Kinouchi Y, Sato H, Ito S, Hida W: Urinary angiotensinogen excretion is associated with blood pressure in obese young adults. Clin Exp Hypertens 38(2): 203-208, 2016
14. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; CKD Prognosis Consortium: Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA 315(2): 164-174, 2016
15. Yamagata K, Makino H, Iseki K, Ito S, Kimura K, Kusano E, Shibata T, Tomita K, Narita I, Nishino T, Fujigaki Y, Mitarai T, Watanabe T, Wada T, Nakamura T, Matsuo S; Study Group for Frontier of Renal Outcome Modifications in Japan (FROM-J): Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial. PLoS One 11(3): e0151422, 2016
16. Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota F, Oki Y,Baba S, Midorikawa S, Morimoto R, Satoh F, Sasano H: Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis. Hum Pathol 53:41-50, 2016
17. Kubota F, Nakamura Y, Konosu-Fukaya S, Azmahani A, Ise K, Yamazaki Y, Kitawaki Y, Felizola SJ, Ono Y, Omata K, Morimoto R, Iwama N, Satoh F, Sasano H: Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative RT-PCR studies. Hum Pathol. 2016 Apr 13. pii: S0046-8177(16)30035-1. doi: 10.1016/j.humpath.2016.03.016. [Epub ahead of print]
18. Suzuki T, Yamaguchi H, Kikusato M, Hashizume O, Nagatoishi S, Matsuo A, Sato T, Kudo T, Matsuhashi T, Murayama K, Ohba Y, Watanabe S, Kanno SI, Minaki D, Saigusa D, Shinbo H, Mori N, Yuri A, Yokoro M, Mishima E, Shima H, Akiyama Y, Takeuchi Y, Kikuchi K, Toyohara T, Suzuki C, Ichimura T, Anzai JI, Kohzuki M, Mano N, Kure S, Yanagisawa T, Tomioka Y, Tohyomizu M, Tsumoto K, Nakada K, Bonventre JV, Ito S, Osaka H, Hayashi KI, Abe T: Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage. J Am Soc Nephrol; 27(7):1925-1932, 2016
19. Nanba K, Chen AX, Omata K, Vinco M, Giordano TJ, Else T, Hammer GD, Tomlins SA, Rainey WE. Molecular Heterogeneity in Aldosterone-Producing Adenomas. J Clin Endocrinol Metab.101(3):999-1007, 2016
20. Harms PW, Collie AM, Hovelson DH, Cani AK, Verhaegen ME, Patel RM, Fullen DR, Omata K, Dlugosz AA, Tomlins SA, Billings SD. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation. Mod Pathol. 29(3):240-248, 2016
21. Nanba K, Omata K, Tomlins SA, Giordano TJ, Hammer G, Rainey WE, Else T. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations. Eur J Endocrinol. 175(2): K1-6, 2016
22. Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Haga T, Hashimoto A, Morimoto R, Aiba S:Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.J Dermatol. 2016 (In Press)
23. Yamamoto T, Miyazaki M, Nakayama M, Yamada G, Matsushima M, Sato M, Sato T, Taguma Y, Sato H, Ito S: Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study. Clin Exp Nephrol. 20(4):595-602, 2016
24. Murakami K, Nakamura Y, Felizola SJ, Morimoto R, Satoh F, Takanami K, Katakami H, Hirota S, Takeda Y, Meguro-Horike M, Horike SI, Unno M, Sasano H: Pancreatic solitary fibrous tumor causing ectopic adrenocorticotropic hormone syndrome; Mol Cell Endocrinol 436: 268-273, 2016
25. Nakayama M, Kabayama S, Ito S: The hydrogen molecule as antioxidant therapy: clinical application in hemodialysis and perspectives; Renal Replacement Therapy 2; 23, 2016
26. Mishima E, Nishimiya K, Fujiwara Y, Nishizawa M, Kiyomoto H, Ito S: Serious Hypocalcemia After Withdrawal of Vitamin D Analog in Bedridden Nonagenarians with Previous Thyroidectomy: A Report of Two Cases; J Am Geriatr Soc 64(6):1374-1376, 2016
27. Ogawa S, Takiguchi J, Shimizu M, Nako K, Okamura M, Kinouchi Y, Ito S: The Reduction in Urinary Glutamate Excretion Is Responsible for Lowering Urinary pH in Pink Urine Syndrome; Tohoku J Exp Med 239(2):103-110, 2016
28. Fushima T, Sekimoto A, Minato T, Ito T, Oe Y, Kisu K, Sato E, Funamoto K, Hayase T, Kimura Y, Ito S, Sato H, Takahashi N: Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in Mice; PLoS One 11(5):e0155426, 2016
29. Oe Y, Hayashi S, Fushima T, Sato E, Kisu K, Sato H, Ito S, Takahashi N: Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy; Arterioscler Thromb Vasc Biol. 36(8):1525-33, 2016
30. Nishikawa T, Omura M, Kawaguchi M, Takatsu A, Satoh F, Ito S, Kurihara I, Itoh H, Yanase T, Shibata H, Oki Y, Naruse M, Sakurai K, Sasamoto H, Kuwa K: Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood; Endocr J. 63(12); 1065-1080, 2016
31. Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, Saigusa D, Miura D, Morikawa-Ichinose T, Saito R, Oba-Yabana I, Oe Y, Kisu K, Naganuma E, Koizumi K, Mokudai T, Niwano Y, Kudo T, Suzuki C, Takahashi N, Sato H, Abe T, Niwa T, Ito S: Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Scientific Reports 6: 36618, 2016
32. Nakamura Y, Yamazaki Y, Tezuka Y, Satoh F, Sasano H: Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance. Tohoku J Exp Med 240(3):183-190, 2016
33. Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, Morimoto R, Nozawa Y, Gomez-Sanchez CE, Tomlins SA, Rainey WE, Ito S, Satoh F, Sasano H: Histopathological classification of cross-sectional image negative hyperaldosteronism. J Clin Endocrinol Metab. 2016 Dec 14:jc20162986. [Epub ahead of print]
34. Li F, Fushima T, Oyanagi G, Townley-Tilson HW, Sato E, Nakada H, Oe Y, Hagaman JR, Wilder J, Li M, Sekimoto A, Saigusa D, Sato H, Ito S, Jennette JC, Maeda N, Karumanchi SA, Smithies O, Takahashi N: Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia. Proc Natl Acad Sci U S A. 113(47):13450-13455, 2016
35. Torigoe A, Sato E, Mori T, Ieiri N, Takahashi C, Ishida Y, Hotta O, Ito S: Comparisons of amino acids, body constituents and antioxidative response between long-time HD and normal HD. Hemodial Int 20 Suppl 1:S17-S24, 2016
36. Kuriyama S, Yaegashi N, Nagami F, Arai T, Kawaguchi Y, Osumi N, Sakaida M, Suzuki Y, Nakayama K, Hashizume H, Tamiya G, Kawame H, Suzuki K, Hozawa A, Nakaya N, Kikuya M, Metoki H, Tsuji I, Fuse N, Kiyomoto H, Sugawara J, Tsuboi A, Egawa S, Ito K, Chida K, Ishii T, Tomita H, Taki Y, Minegishi N, Ishii N, Yasuda J, Igarashi K, Shimizu R, Nagasaki M, Koshiba S, Kinoshita K, Ogishima S, Takai-Igarashi T, Tominaga T, Tanabe O, Ohuchi N, Shimosegawa T, Kure S, Tanaka H, Ito S, Hitomi J, Tanno K, Nakamura M, Ogasawara K, Kobayashi S, Sakata K, Satoh M, Shimizu A, Sasaki M, Endo R, Sobue K, Tohoku Medical Megabank Project Study Group T, Yamamoto M: The Tohoku Medical Megabank Project: Design and Mission. J Epidemiol. 26(9):493-511, 2016

- Top | Home -

2015年
1. Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Teramukai S, Higaki J, Ito S, Shimada K: Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial. Hypertens Res 38(1):89-96, 2015
2. Satoh F, Morimoto R, Ono Y, Iwakura Y, Omata K, Kudo M, Takase K, Seiji K, Sasamoto H, Honma S, Okuyama M, Yamashita K, Gomez-Sanchez CE, Rainey WE, Arai Y, Sasano H, Nakamura Y, Ito S: Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. Hypertension 65(5):1096-1102, 2015
3. Takeuchi Y, Mishima E, Shima H, Akiyama Y, Suzuki C, Suzuki T, Kobayashi T, Suzuki Y, Nakayama T, Takeshima Y, Vazquez N, Ito S, Gamba G, Abe T: Exonic Mutations in the SLC12A3 Gene Cause Exon Skipping and Premature Termination in Gitelman Syndrome. J Am Soc Nephrol 26(2):271-279, 2015
4. Fujihara M, Yokoi Y, Abe T, Soga Y, Yamashita T, Miyashita Y, Nakamura M, Yokoi H, Ito S: Clinical Outcomes of Renal Artery Stenting for Hypertension and Chronic Kidney Disease over 12 Months in J-RAS study; A Prospective, Single-Arm, Multi-center Clinical Study. Circulation J 79(2): 351-359 , 2015
5. Narumi K, Hirose T, Sato E, Mori T, Kisu K, Ishikawa M, Totsune K, Ishii T, Ichihara A, Nguyen G, Sato H, Ito S: Functional (pro)renin receptor is expressed in human lymphocytes and monocytes. Am J Physiol Renal Physiol 308(5):F487-499, 2015
6. Kunikata H, Aizawa N, Kudo M, Mugikura S, Nitta F, Morimoto R, Iwakura Y, Ono Y, Satoh F, Takahashi H, Ito S, Takahashi S, Nakazawa T: Relationship of Ocular Microcirculation, measured by Laser Speckle Flowgraphy, and Silent Brain Infarction in Primary Aldosteronism. PLOS ONE 10(2):e0117452, 2015
7. Ito S: In Vitro Study of the Juxtaglomerular Apparatus and Its Implications in the Chronic Kidney Disease (Arthur C. Corcoran Memorial Lecture). Hypertension 65; 970-975, 2015
8. Senda M, Ogawa S, Nako K, Okamura M, Sakamoto T, Ito S: The strong relation between post-hemodialysis blood methylglyoxal levels and post-hemodialysis blood glucose concentration rise. Clin Exp Nephrol 19(3); 527-533, 2015
9. Ogawa S, Takiguchi J, Nako K, Okamura M, Sakamoto T, Kabayama S, Mori T, Kinouchi Y, Ito S: Elucidation of the etiology and characteristics of pink urine in young healthy subjects. Clin Exp Nephrol. 19(5); 822-829, 2015
10. Ogawa S, Nako K, Okamura M, Sakamoto T, Ito S: Stabilization of postprandial blood glucose fluctuations by addition of GLP-analog administration to intensive insulin therapy. J Diabetes Invest6(4); 436-442,2015
11. Yamamoto T, Nakayama M, Miyazaki M, Matsushima M, Sato T, Taguma Y, Sato H, Ito S: Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study. Clin Exp Nephrol. 19(5); 878-886, 2015
12. Konosu-Fukaya S, Nakamura Y, Satoh F, Felizola SJ, Maekawa T, Ono Y, Morimoto R, Ise K, Takeda K, Katsu K, Fujishima F, Kasajima A, Watanabe M, Arai Y, Gomez-Sanchez EP, Gomez-Sanchez CE, Doi M, Okamura H, Sasano H: 3β-hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. Mol Cell Endocrinol 408:205-212, 2015
13. Felizola SJ, Katsu K, Ise K, Nakamura Y, Arai Y, Satoh F, Sasano H: Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues. Endocr Pathol. 26(2):119-128, 2015
14. Mishima E, Hashimoto J, Akiyama Y, Seiji K, Takase K, Abe T, Ito S: Posterior reversible encephalopathy syndrome treated with renin-angiotensin system blockade. J Neurol Sci 355(1-2):219-221, 2015
15. Hashimoto J, Ito S: Aortic Blood Flow Reversal Determines Renal Function: Potential Explanation for Renal Dysfunction Caused by Aortic Stiffening in Hypertension. Hypertension 66(1):61-67, 2015
16. Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K, Tomioka Y, Ito S, Soga T, Abe T: Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. J Am Soc Nephrol 26(8):1787-1794, 2015
17. Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, Kimura K, Suzuki Y, Wada T, Ogawa S, Inaba M, Kanno Y, Shigematsu T, Masakane I, Tsuchiya K, Honda K, Ichikawa K, Shide K: A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. Clin Exp Nephrol 19(1):1-5, 2015
18. Iwamori S, Sato E, Saigusa D, Yoshinari K, Ito S, Sato H, Takahashi N: A Novel and Sensitive Assay for Heme Oxygenase Activity. Am J Physiol Renal Physiol. 209(7); F667-671, 2015
19. Satoh F, Morimoto R, Seiji K, Satani N, Ota H, Iwakura Y, Ono Y, Kudo M, Nezu M, Omata K, Tezuka Y, Kawasaki Y, Ishidoya S, Arai Y, Takase K, Nakamura Y, McNamara K, Sasano H, Ito S: Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism? Eur J Endocrinol. 173(4); 465-477, 2015
20. Nakamura Y, Yamazaki Y, Konosu-Fukaya S, Ise K, Satoh F, Sasano H: Aldosterone biosynthesis in the human adrenal cortex and associated disorders. J Steroid Biochem Mol Biol. 153: 57-62, 2015
21. Sato M, Morimoto R, Seiji K, Iwakura Y, Ono Y, Kudo M, Satoh F, Ito S, Ishibashi T, Takase K: Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan; Horm Metab Res 47(11); 826-832, 2015
22. Rong R, Ito O, Mori N, Muroya Y, Tamura Y, Mori T, Ito S, Takahashi K, Totsune K, Kohzuki M: Expression of (pro)renin receptor and its upregulation by high salt intake in the rat nephron. Peptides 63:156-162, 2015
23. Ito S, Satoh M, Tamaki Y, Gotou H, Charney A, Okino N, Akahori M, Zhang J: Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Hypertens Res 38(4):269-275, 2015
24. Mishima E, Jinno D, Akiyama Y, Itoh K, Nankumo S, Shima H, Kikuchi K, Takeuchi Y, Elkordy A, Suzuki T, Niizuma K, Ito S, Tomioka Y, Abe T: Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides. PLoS One 25;10(11):e0143756, 2015
25. Nakamura Y, Yamazaki Y, Felizola SJ, Ise K, Morimoto R, Satoh F, Arai Y, Sasano H: Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis. Endocrinol Metab Clin North Am. 44(2); 399-410, 2015
26. Saruta T, Ogihara T, Saito I, Rakugi H, Shimamoto K, Matsuoka H, Teramukai S, Higaki J, Ito S, Shimada K: Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability. Hypertens Res 38(2): 132-136, 2015
27. Oba I, Mori T, Chida M, Kurasawa N, Naganuma E, Sato E, Koizumi K, Sato S, Tsuchikawa M, Ito S: Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients. Adv Perit Dial 31: 11-16, 2015
28. Ogawa S, Nako K, Okamura M, Ito S: Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes. BMJ Open Diabetes Res Care 3(1):e000097, 2015
29. Endo S, Mishima E, Takeuchi Y, Ohi T, Ishida M, Yanai M, Kiyomoto H, Nagasawa T, Ito S: Periodontitis-associated septic pulmonary embolism caused by Actinomyces species identified by anaerobic culture of bronchoalveolar lavage fluid: a case report. BMC Infect Dis 15:552, 2015
30. Saito-Hakoda A, Uruno A, Yokoyama A, Shimizu K, Parvin R, Kudo M, Saito-Ito T, Sato I, Kogure N, Suzuki D, Shimada H, Yoshikawa T, Fujiwara I, Kagechika H, Iwasaki Y, Kure S, Ito S, Sugawara A: Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression. PLoS One 10(12):e0141960, 2015
31. Kurasawa N, Mori T, Naganuma E, Sato E, Koizumi K, Sato S, Oba I, Tsuchikawa M, Ito S: Association Between Home Blood Pressure and Body Composition by Bioimpedance Monitoring in Patients Undergoing Peritoneal Dialysis. Adv Perit Dial 31:38-44, 2015
32. Kadakia KC, Tomlins SA, Sanghvi SK, Cani AK, Omata K, Hovelson DH, Liu CJ, Cooney KA. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment. J Hematol Oncol. 8(1):109, 2015
33. Suzuki T, Yamaguchi H, Kikusato M, Matsuhashi T, Matsuo A, Sato T, Oba Y, Watanabe S, Minaki D, Saigusa D, Shimbo H, Mori N, Mishima E, Shima H, Akiyama Y, Takeuchi Y, Yuri A, Kikuchi K, Toyohara T, Suzuki C, Kohzuki M, Anzai J, Mano N, Kure S, Yanagisawa T, Tomioka Y, Toyomizu M, Ito S, Osaka H, Hayashi K, Abe T: Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial Diseases. Tohoku J Exp Med 236(3):225-232, 2015

- Top | Home -

2014年
1. Matsuda K, Uruno A, Kogure N, Sugawara K, Shimada H, Nezu M, Saito-Ito T, Iki Y, Kudo M, Shimizu K, Sato I, Yoshikawa T, Satoh F, Ito R, Yokoyama A, Rainey WE, Saito-Hakoda A, Ito S, Sugawara A: Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells. Mol Cell Endocrinol 383:60-68, 2014
2. Shimamoto K, Hasebe N, Ito S, Kario K, Kimura K, Dohi Y, Kawano Y, Rakugi H, Horiuchi M, Imaizumi T, Ohya Y: Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study. Hypertens Res 37(1):69-75, 2014
3. Funabiki M, Kato H, Miyachi Y, Toki H, Motegi H, Inoue M, Minowa O, Yoshida A, Deguchi K, Sato H, Ito S, Shiroishi T, Takeyasu K, Noda T, Fujita T.  Autoimmune Disorders Associated with Gain of Function of the Intracellular Sensor MDA5. Immunity 40(2):199-212, 2014
4. Doi M, Satoh F, Maekawa T, Nakamura Y, Fustin JM, Tainaka M, Hotta Y, Takahashi Y, Morimoto R, Takase K, Ito S, Sasano H, Okamura H: Isoform-specific monoclonal antibodies against 3β-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism. J Clin Endocrinol Metab. 99(2); E257-262, 2014
5. Sato H, Takahashi N, Sato E, Kisu K, Ito S, Saito T: Pathology of glomerular lipidosis; Clin Exp Nephrol 18(2):194-196, 2014
6. Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, Arai Y, Nakamura Y, Sasano H, Ito S, Satoh F. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: Renal outcome of 213 cases. J Clin Endocrinol Metab 99(5):1593-1598, 2014
7. Terawaki H, Zhu WJ, Matsuyama Y, Terada T, Takahashi Y, Sakurai K, Kabayama S, Miyazaki M, Itami N, Nakazawa R, Ito S, Era S, Nakayama M: Effect of a hydrogen (H2 )-enriched solution on the albumin redox of hemodialysis patients. Hemodial Int 18(2):459-466, 2014
8. Phaeochromocytoma Study Group in Japan, Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M: Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21(3):405-414, 2014
9. Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M: Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 21(3):L13-16, 2014
10. Kudo M, Matsuda K, Sugawara K, Iki Y, Kogure N, Saito-Ito T, Shimizu K, Sato I, Yoshikawa T, Uruno A, Ito R, Yokoyama A, Saito-Hakoda A, Ito S, Sugawara A: ARB affects nicotine-induced gene expression profile in human coronary artery endothelial cells; World J Hypertens 4(1); 7-14, 2014
11. Hashimoto J: Central Hemodynamics and Target Organ Damage in Hypertension; Tohoku J Exp Med 233; 1-8, 2014
12. Mishima E, Inoue C, Saigusa D, Inoue R, Ito K, Suzuki Y, Jinno D, Tsukui Y, Akamatsu Y, Araki M, Araki K, Shimizu R, Shinke H, Suzuki T, Takeuchi Y, Shima H, Akiyama Y, Toyohara T, Suzuki C, Saiki Y, Tominaga T, Miyagi S, Kawagisihi N, Soga T, Ohkubo T, Yamamura K, Imai Y, Masuda S, Sabbisetti V, Ichimura T, Mount DB, Bonventre JV, Ito S, Tomioka Y, Itoh K, Abe T: Conformational Change in Transfer RNA Is an Early Indicator of Acute Cellular Damage; J Am Soc Nephrol 25(10); 2316-2326, 2014
13. Kudo M, Satoh F, Aoki S, Morimoto R, Iwakura Y, Ono Y, Matsuda K, Sugawara A, Yoshida K, Sato K, Ito S: Assisting the diagnosis of Cushing syndrome by pattern recognition methods, using a combination of eight routine tests and their multiple correlation with serum cortisol; Biomedicine & Aging Pathology 4; 257-264, 2014
14. Ono Y, Nakamura Y, Maekawa T, Felizola SJ, Morimoto R, Iwakura Y, Kudo M, Seiji K, Takase K, Arai Y, Gomez-Sanchez CE, Ito S, Sasano H, Satoh F: Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension 64(2):438-44, 2014
15. Nakamura Y, Maekawa T, Felizola SJ, Satoh F, Qi X, Velarde-Miranda C, Plonczynski MW, Ise K, Kikuchi K, Rainey WE, Gomez-Sanchez EP, Gomez-Sanchez CE, Sasano H. Adrenal CYP11B1/2 expression in primary aldosteronism: Immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol ;392(1-2):73-79, 2014
16. Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, Satoh F, Young WF Jr, Rossi GP. Response to implementation of rapid cortisol during adrenal vein sampling. Hypertension 63(4):e89, 2014
17. Nakamura Y, Hattangady NG, Ye P, Satoh F, Morimoto R, Ito-Saito T, Sugawara A, Ohba K, Takahashi K, Rainey WE, Sasano H. Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA). Mol Cell Endocrinol. 384(1-2):102-8, 2014
18. Felizola SJ, Nakamura Y, Ono Y, Kitamura K, Kikuchi K, Onodera Y, Ise K, Takase K, Sugawara A, Hattangady N, Rainey WE, Satoh F, Sasano H. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J Mol Endocrinol 52(2):159-67, 2014
19. Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 383(1-2):111-7, 2014
20. Takanami K, Kaneta T, Morimoto R, Satoh F, Nakamura Y, Takase K, Takahashi S. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not? Ann Nucl Med 28(2):145-53, 2014
21. Felizola SJ, Nakamura Y, Arata Y, Ise K, Satoh F, Rainey WE, Midorikawa S, Suzuki S, Sasano H. Metallothionein-3 (MT-3) in the Human Adrenal Cortex and its Disorders. Endocr Pathol 25(3):229-235, 2014
22. Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, Satoh F, Young WF Jr. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 63(1):151-6, 2014
23. Felizola SJ, Nakamura Y, Satoh F, Morimoto R, Kikuchi K, Nakamura T, Hozawa A, Wang L, Onodera Y, Ise K, McNamara KM, Midorikawa S, Suzuki S, Sasano H. Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway. Mol Cell Endocrinol 382(1):170-7, 2014
24. Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, Sasano H, Takeda Y, Shibata H, Sone M, Satoh F, Yamada M, Ueshiba H, Katabami T, Iwasaki Y, Tanaka H, Tanahashi Y, Suzuki S, Hasegawa T, Katsumata N, Tajima T, Yanase T. Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocr J 61(1):35-40, 2014
25. Kato J, Nakayama M, Zhu WJ, Yokoo T, Ito S: Ischemia/Reperfusion of Unilateral Kidney Exaggerates Aging-Induced Damage to the Heart and Contralateral Kidney. Nephron Exp Nephrol 126(4):183-190, 2014
26. Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahashi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S; COLM Investigators: Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial1. J Hypertens 32(10):2054-2063, 2014
27. Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M, and Phaeochromocytoma Study Group in Japan; Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma; Endocrine-Related Cancer 21(3); 405-414, 2014
28. Hashimoto J, Ito S: Central pulse pressure links microalbuminuria with plasma B type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension; Journal of Hypertension 32; 1665-1671, 2014
29. Uruno A, Saito-Hakoda A, Yokoyama A, Kogure N, Matsuda K, Parvin R, Shimizu K, Sato I, Kudo M, Yoshikawa T, Kagechika H, Iwasaki Y, Ito S, Sugawara A: Retinoic acid receptor-α up-regulates proopiomelanocortin gene expression in AtT20 corticotroph cells. Endocr J 61(11):1105-1114, 2014
30. Monticone S, Satoh F, Viola A, Fischer E, Vonend O, Bernini G, Lucatello B, Quinkler M, Ronconi V, Morimoto R, Kudo M, Degenhart C, Gao X, Carrara D, Willenberg HS, Rossato D, Mengozzi G, Riester A, Paci E, Iwakura Y, Burrello J, Maccario M, Giacchetti G, Veglio F, Ito S, Reincke M, Mulatero P: Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab 99(11):4158-4166, 2014
31. Felizola SJ, Maekawa T, Nakamura Y, Satoh F, Ono Y, Kikuchi K, Aritomi S, Ikeda K, Yoshimura M, Tojo K, Sasano H: Voltage-gated calcium channels in the human adrenal and primary aldosteronism. J Steroid Biochem Mol Biol 144 Pt B:410-416, 2014
32. Sasano H, Satoh F, Nakamura Y: Roles of the pathologist in evaluating surrogate markers for medical therapy in adrenocortical carcinoma. Endocr Pathol 25(4):366-370, 2014
33. Nakamura Y, Felizola SJ, Satoh F, Konosu-Fukaya S, Sasano H: Dissecting the molecular pathways of primary aldosteronism. Pathol Int 64(10):482-489, 2014
34. Sato N, Nakamura Y, Takanami K, Ono Y, Omata K, Morimoto R, Satoh F, Ise K, Yamada S, Kasajima A, Fujishima F, Watanabe M, Arai Y, Sasano H: Case report: adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1. Endocr Pathol 25(4):410-415, 2014
35. Felizola SJ, Nakamura Y, Ozawa Y, Ono Y, Morimoto R, Midorikawa S, Suzuki S, Satoh F, Sasano H: Activating transcription factor 3 (ATF3) in the human adrenal cortex: its possible involvement in aldosterone biosynthesis. Tohoku J Exp Med 234(4):249-254, 2014

- Top | Home -

2013
1. Ito D, Ito O, Cao P, Mori N, Suda C, Muroya Y, Takashima K, Ito S, Kohzuki M: Effects of exercise training on nitric oxide synthase in the kidney of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 40(2):74-82, 2013
2. Konno S, Hozawa A, Miura Y, Ito S, Munakata M: High-normal diastolic blood pressure is a risk for development of microalbuminusira in the general population: the Watari study; J Hypertens 31; 798-804, 2013
3. Chen X, Mori T, Guo Q, Hu C, Ohsaki Y, Yoneki Y, Zhu W, Jiang Y, Endo S, Nakayama K, Ogawa S, Nakayama M, Miyata T, Ito S: Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats. Hypertens Res 36; 361-367, 2013
4. Hoshikawa S, Nakagawa Y, Ozaki H, Takahashi Y, Ito S, Yoshida K, Mori K: Effects of green tea polyphenols on iodide-induced autoimmune thyroiditis in nonobese diabetic mice; Immunol Invest 42(3):235-246, 2013
5. Rege J, Nakamura Y, Satoh F, Morimoto R, Kennedy MR, Layman LC, Honma S, Sasano H, Rainey WE: Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J Clin Endocrinol Metab 98; 1182-1188, 2013
6. Hashimoto J, Ito S:Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta: Potential Implication for Retrograde Embolic Stroke in Hypertension. ;Hypertension 62; 542-549, 2013
7. Ogawa S, Matsushima M, Mori T, Okamura M, Senda M, Sakamoto T, Nako K, Ito S: Identification of the Stages of Diabetic Nephropathy at Which Angiotensin II Receptor Blockers Most Effectively Suppress Albuminuria; Am J Hypertens 26(9):1064-1069, 2013
8. Terawaki H, Nakayama M, Miyazawa E, Murata Y, Nakayama K, Matsushima M, Miyazaki M, Sato H, Sato M, Sato T, Taguma Y, Ito S: Erratum to: Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol 17(4): 554, 2013
9. Terawaki H, Nakayama M, Miyazawa E, Murata Y, Nakayama K, Matsushima M, Miyazaki M, Sato H, Sato M, Sato T, Taguma Y, Ito S: Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol 17(4):549-553, 2013
10. Ogawa S, Abe T, Nako K, Okamura M, Senda M, Sakamoto T, Ito S; DIMS Study Group: Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes; Tohoku J Exp Med 231(1):63-74, 2013
11. Imai E, Haneda M, Chan JCN, Yamasaki T, Kobayashi F, Ito S, Makino H: Reduction and residual proteinuria and therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria); Nephrol Dial Transplant 28(10): 2526-2534, 2013
12. Ogawa S, Nako K, Okamura M, Senda M, Sakamoto T, Abe T, Ito S: A Decline in Glomerular Filtration Rate Rather than Renal Arterial Stenotic Lesions, per se, Predicts Cardiovascular-Renal Events in Type 2 Diabetic Patients; Circ J 77(11):2816-2822, 2013
13. Souma T, Yamazaki S, Moriguchi T, Suzuki N, Hirano I, Pan X, Minegishi N, Abe M, Kiyomoto H, Ito S, Yamamoto M: Plasticity of renal erythropoietin-producing cells governs fibrosis; J Am Soc Nephrol 24(10):1599-1616, 2013
14. Mori T, Oba I, Koizumi K, Kodama M, Shimanuki M, Tanno M, Chida M, Saito M, Kiyomoto H, Miyazaki M, Ogawa S, Sato H, Ito S: Beneficial Role of Tolvaptan in the Control of Body Fluids Without Reductions in Residual Renal Function in Patients Undergoing Peritoneal Dialysis; Advances in Peritoneal Dialysis 29: 33-37, 2013
15. Okuda H, Abe M, Kiyomoto H : A rare case among hypertensive patients: how do we handle reninomas? Intern Med 52(17) ;1853, 2013
16. Umemoto S, Ogihara T, Rakugi H, Matsumoto M, Kitagawa K, Shimada K, Higaki J, Ito S, Suzuki H, Ohashi Y, Saruta T, Matsuzaki M, on behalf of the Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group: Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial; Hypertens Res 36(12): 1088-1095, 2013
17. Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Shimamoto K, Satuta T: Combination Therapy for Hypertension in Patients with CKD –a Sub-analysis of the Combination Therapy of Hypertension to Precent Cardiovascular Events; Hypertens Res 36(11): 947-958, 2013
18. Imai E, Haneda M, Yamasaki T, Kobayashi F, Harada A, Ito S, Chan JC, Makino H: Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension); Hypertens Res 36(12):1051-1059, 2013
19. Oe Y, Soma J, Sato H, Ito S: Heavy chain deposition disease: an overview; Clin Exp Nephrol 17(6):771-778, 2013
20. Terawaki H, Yamagishi S, Funakoshi Y, Matsuyama Y, Terada T, Nakayama K, Ogura M, Hosoya T, Ito S, Era S, Nakayama M: Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis. Ther Apher Dial 17(6):625-630, 2013
21. Zhu WJ, Nakayama M, Mori T, Hao K, Terawaki H, Katoh J, Kabayama S, Ito S: Amelioration of cardio-renal injury with aging in dahl salt-sensitive rats by H2-enriched electrolyzed water. Med Gas Res 3(1):26, 2013
22. Yamamoto H, Kaneko K, Ohba K, Morimoto R, Hirose T, Satoh F, Totsune K, Takahashi K. Increased expression of (pro)renin receptor in aldosterone-producing adenomas. Peptides. 49:68-73, 2013
23. Felizola SJ, Nakamura Y, Hui XG, Satoh F, Morimoto R, M McNamara K, Midorikawa S, Suzuki S, Rainey WE, Sasano H. Estrogen-related receptor α in normal adrenal cortex and adrenocortical tumors: involvement in development and oncogenesis. Mol Cell Endocrinol 365(2):207-11, 2013

- Top | Home -

2012
1. Guo Q, Mori T, Jiang Y, Hu C, Ohsaki Y, Yoneki Y, Nakamichi T, Ogawa S, Sato H, Ito S. Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats. Hypertens Res. 35; 48-54, 2012
2. Ohsaki Y, O'Connor P, Mori T, Ryan RP, Dickinson BC, Chang CJ, Lu Y, Ito S, Cowley AW Jr: Increase of sodium delivery stimulates the mitochondrial respiratory chain H2O2 production in rat renal medullary thick ascending limb; Am H Physiol Renal Physiol 302; F95-F102, 2012
3. Sugawara A, Sato H, Ito S: Diabetes and Hepatitis C infection in Dialysis Patients: The Present Situation in Japan; Nephrol-Urol Mon 4(1); 391-392, 2012
4. Ito S:Cardiorenal connection in chronic kidney disease.Clin Exp Nephrol 16; 8-16, 2012
5. Menne J, Izzo Jr. JL, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, Haller H, for the ROADMAP investigators: Prevention of microalbuminuria in patients with type 2 diabetes and hypertension; J Hypertens 30; 811-818, 2012
6. Monticone S, Satoh F, Giacchetti G, Viola A, Morimoto R, Kudo M, Iwakura Y, Ono Y, Turchi F, Paci E, Veglio F, Boscaro M, Rainey W, Ito S, Mulatero P: Effect of adrenocorticotropic hormone stimulation during a
7. Mori T, Ogawa S, Cowely AW Jr, Ito S: Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes. Clin Exp Pharmacol Physiol 39(1):125-131, 2012
8. Ogihara T, Matsuzaki M, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial. Hypertens Res 35(4):441-448, 2012
9. Hashimoto J, Ito S: Central Blood Pressure and Prediction of Cardiovascular Events. Current Hypertension Review 8; 108-113, 2012
10. Sofue T, Kiyomoto H, Kobori H, Urushihara M, Nishijima Y, Kaifu K, Hara T, Matsumoto S, Ichimura A, Ohsaki H, Hitomi H, Kawachi H, Hayden MR, Whaley-Connell A, Sowers JR, Ito S, Kohno M, Nishiyama A: Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats. Am J Hypertens 25(5); 604-611, 2012
11. Ito S: Cardiorenal syndrome; an evolutionary point of view; Hypertension 60; 589-595, 2012
12. Ito S, Naritomi H, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res 35(8):867-873, 2012
13. Ogawa S, Ishiki M, Nako K, Okamura M, Senda M, Sakamoto T, Ito S: Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitus. BMJ Open 13;2(2):e000830, 2012
14. Hu C, Mori T, Lu Y, Guo Q, Sun Y, Yoneki Y, Ohsaki Y, Nakamichi T, Oba I, Sato E, Ogawa S, Dickinson BC, Chang CJ, Miyata T, Sato H, Ito S: Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation. J Hypertens 30(8):1620-1631, 2012
15. Nagasawa T, Mori T, Ohsaki Y, Yoneki Y, Guo Q, Sato E, Oba I, Ito S: Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats. Hypertens Res 35(10):1024-1031, 2012
16. Senda M, Ogawa S, Nako K, Okamura M, Sakamoto T, Ito S: The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. Endocr J 59(10); 889-894, 2012
17. Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C, Deinum J, Fischer E, Gordon R, Kickuth R, Kline G, Lacroix A, Magill S, Miotto D, Naruse M, Nishikawa T, Omura M, Pimenta E, Plouin PF, Quinkler M, Reincke M, Rossi E, Rump LC, Satoh F, Schultze Kool L, Seccia TM, Stowasser M, Tanabe A, Trerotola S, Vonend O, Widimsky J Jr, Wu KD, Wu VC, Pessina AC. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 97(5):1606-1614, 2012
18. Mori K, Nakagawa Y, Ozaki H. Does the gut microbiota trigger Hashimoto's thyroiditis? Discov Med 14(78):321-326, 2012
19. Guo Q, Mori T, Jiang Y, Hu C, Ohsaki Y, Yoneki Y, Nakamichi T, Ogawa S, Sato H, Ito S. Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats. Hypertens Res. 35; 48-54, 2012
20. Akiyama Y, Takeuchi Y, Kikuchi K, Mishima E, Yamamoto Y, Suzuki C, Toyohara T, Suzuki T, Hozawa A, Ito S, Soga T, Abe T: A metabolomic approach to clarifying the effect of AST-120 on 5/6 nephrectomized rats by capillary electrophoresis with mass spectrometry (CE-MS). Toxins (Basel) 4(11):1309-1322, 2012
21. Sugawara A, Uruno A, Matsuda K, Saito-Ito T, Funato T, Saito-Hakoda A, Kudo M, Ito S: Effects of PPARγ agonists against vascular and renal dysfunction. Curr Mol Pharmacol 5(2):248-254, 2012
22. Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C, Deinum J, Fischer E, Gordon R, Kickuth R, Kline G, Lacroix A, Magill S, Miotto D,Naruse M, Nishikawa T, Omura M, Pimenta E, Plouin PF, Quinkler M, Reincke M, Rossi E, Rump LC, Satoh F, Schultze Kool L, Seccia TM, Stowasser M,Tanabe A, Trerotola S, Vonend O, Widimsky J Jr, Wu KD, Wu VC, Pessina AC. The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism. J Clin Endocrinol Metab 97(5):1606-14, 2012
23. Nakamichi T, Miyazaki M, Nakayama K, Sato M, Akiu N, Sato T, Sato H, Ito S: Fabry's disease discovered with chance urinary mulberry cells: a case report. CEN Case Rep 2(1):49-52, 2012

- Top | Home -

2011
1. Morimoto R, Kudo M, Murakami O, Takase K, Ishidoya S, Nakamura Y, Ishibashi T, Takahashi S, Arai Y, Suzuki T, Sasano H, Ito S, Satoh F: Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma. J Hum Hypertens. 25(2):114-121, 2011.
2. Uruno A, Matsuda K, Noguchi N, Yoshikawa T, Kudo M, Satoh F, Rainey WE, Hui XG, Akahira JI, Nakamura Y, Sasano H, Okamoto H, Ito S, Sugawara A: Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production. J Mol Endcrinol. 46(1):37-49, 2011.
3. Terawaki H, Nakao M, Nakayama K, Nakayama M, Kimura A, Takane K, Mitome J, Hamaguchi A, Ogura M, Yokoyama K, Ito S, Hosoya T. Peritoneal clearance and transport of methylglyoxal. Nephrol Dial Transplant. 26(2):753-764, 2011.
4. Ogawa S, Ishiki M, Nako K, Okamura M, Senda M, Mori T, Ito S. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes. Tohoku J Exp Med. 223(2):133-135, 2011.
5. Kuriyama C, Mori K, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Inoue M, Ohta M, Yoshida K: Erythrocyte zinc concentration as an indicator to distinguish painless thyroiditis-associated transient hypothyroidism from permanent hypothyroidism. Endocr J. 58(1):59-63, 2011.
6. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G; ROADMAP Trial Investigators: Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 364: 907-917, 2011.
7. Ogawa S, Nako K, Okamura M, Senda M, Mori T, Ito S.  Aliskiren reduces albuminuria and oxidative stress, and elevates glomerular filtration rates in Japanese patients with advanced diabetic nephropathy. Hypertens Res. 34(3):400-401, 2011.
8. Satoh F, Morimoto R, Iwakura Y, Ono Y, Kudo M, Takase K, Ito S: Primary aldosteronism : A Japanese perspective. Rev Endocr Metab Disord. 12:11-14, 2011.
9. Ota K, Dohi Y, Brydun A, Nakanome A, Ito S, Igarashi K. Identification of Senescence-Associated Genes and their Networks under Oxidative Stress by the Analysis of Bach1. Antioxid Redox Signal. 14:2441-2451, 2011.
10. Ishidoya S, Kaiho Y, Ito A, Morimoto R, Satoh F, Ito S, Ishibashi T, Nakamura Y, Sasano H, Arai Y: Single-center Outcome of Laparoscopic Unilateral Adrenalectomy for Patients With Primary Aldosteronism: Lateralizing Disease Using Results of Adrenal Venous Sampling. Urology. Jul;78(1):68-73, 2011.
11. Zhu WJ, Nakayama M, Mori T, Nakayama K, Katoh J, Murata Y, Sato T, Kabayama S, Ito S: Intake of water with high levels of dissolved hydrogen (H2) suppresses ischemia-induced cardio-renal injury in Dahl salt-sensitive rats. Nephrol Dial Transplant. Jul;26(7):2112-8 2011.
12. Toyohara T, Suzuki T, Akiyama Y, Yoshihara D, Takeuchi Y, Mishima E, Kikuchi K, Suzuki C, Tanemoto M, Ito S, Nagao S, Soga T, Abe T: Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clin Exp Nephrol. 15(5):676-87, 2011.
13. Morohoshi K, Yoshida K, Nakagawa Y, Hoshikawa S, Ozaki H, Takahashi Y, Ito S, Mori K. Effects of synthetic retinoid Am80 on iodide-induced autoimmune thyroiditis in nonobese diabetic mice; Cell Immunol. 270(1):1-4, 2011.
14. Aoki S, Hoshi K, Kawakami J, Sato K, Sato K, Mori K, Sugawara A, Saito Y, Yoshida K. Assisting the diagnosis of Graves' hyperthyroidism with pattern recognition methods and a set of three routine tests parameters, and their correlation with free T4 levels: extension to male patients. Biomed Pharmacother. 65(2):95-104, 2011.
15. Mori K, Yoshida K, Ishii K, Morohoshi K, Nakagawa Y, Hoshikawa S, Ozaki H, Takahashi Y, Ito S. Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice. Autoimmunity. 44(6):483-489, 2011.
16. Morohoshi K, Osone M, Yoshida K, Nakagawa Y, Hoshikawa S, Ozaki H, Takahashi Y, Ito S, Mori K. The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in nonobese diabetic mice. Autoimmunity. 44(6):490-495, 2011.
17. Kazuki Morohoshi, Yurie Takahashi, Kouki Mori. Viral Infection and Innate Pattern Recognition Receptors in Induction of Hashimoto's Thyroiditis. Discovery Medicine. 12(67):505-511, 2011.
18. Nakayama M, Miyazawa E, Kato J, Murata Y, Nakayama K, Matsushima M, Sato H, Sato T, Miyazaki M, Taguma Y, Ito S: Uric Acid and Patients Outcomes in a Cohort of Chronic Kidney Disease and Hypertension; The Gonryo Study; Nephrol Dial Transplant. (In Press)
19. Nakagawa Y, Hoshikawa S, Ozaki H, Mori K. Acute thyroid swelling after fine-needle aspiration biopsy. International Journal of Case Reports and Images. 2(11):28-29, 2011.

- Top | Home -

2010
1. Takahashi Y, Nakagawa Y, Fujishima F, Mori K: A swollen index finger as a presentation of thyroid dermopathy; Intern Med 49; 1831, 2010
2. Mori K, Yoshida K: Viral infection in induction of Hashimoto's thyroiditis - a key player or just a bystander?; Curr Opin Endocrinol Diabetes Obes 17; 418-424, 2010
3. Takahashi K, Shoji I, Shibasaki A, Kato I, Hiraishi K, Yamamoto H, Kaneko K, Murakami O, Morimoto R, Satoh F, Ito S, Totsune K: Presence of Kisspeptin-like Immunoreactivity in Human Adrenal Glands and Adrenal Tumors; J Mol Neurosci 41(1):138-44, 2010
4. Miyazawa N, Abe M, Souma T, Tanemoto M, Abe T, Nakayama M Ito S: Methylglyoxal augments intracellular oxidative stress in human aortic endothelial cells; Free Radic Res 44(1); 101-107, 2010
5. Ito S, Nakura N, Le Breton S, Keefe D: Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction; Hypertens Res 33; 62-66, 2010
6. Ito S: Usefulness of RAS inhibition depends on baseline albuminuria; Nature Reviews Nephrology 6; 10-11, 2010
7. Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL Jr, Katayama S, Ito S, Mimran A, Menne J, Rump LC, Januszewicz A, Haller H: Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study; Diabetologia 53; 49-57, 2010
8. Ito S: Controversies on Obesity and CKD; Circulation Journal 74; 428-429, 2010
9. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kukuchi K, Ito S, Eto T, Kimura G, Imaizumi T, Takishita S, Ueshima H for the Valsartan in Elderly Isolated Systolic Hypertension Study Group: Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly. Valsartan in Elderly Isolated Systolic Hypertension Study; Hypertenson 56; 196-202, 2010
10. Yamagata K, Makino H, Akizawa T, Iseki K, Itoh S, Kimura K, Koya D, Narita I, Mitarai T, Miyazaki M, Tsubakihara Y, Watanabe T, Wada T, Sakai O; Advisory Committee for FROM-J. Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol 14(2):144-151, 2010
11. Nakayama M, Sato T, Sato H, Yamaguchi Y, Obara K, Kurihara I, Sato K, Hotta O, Seino J, Miyata M, Takeuchi K, Nakayama K, Matsushima M, Otaka T, Kinoshita Y, Taguma Y, Ito S. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol 14(4):333-339, 2010
12. Ogawa S, Nakayama K, Nakayama M, Mori T, Matsushima M, Okamura M, Senda M, Nako K, Miyata T, Ito S: Methylglyoxal Is a Predictor in Type 2 Diabetic Patients of Intima-Media Thickening and Elevation of Blood Pressure. Hypertension 56(3):471-476, 2010
13. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T: Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33(9):944-952, 2010
14. Abe M, Toyohara T, Ishii A, Suzuki T, Noguchi N, Akiyama Y, Shiwaku HO, Nakagomi-Hagihara R, Zheng G, Shibata E, Souma T, Shindo T, Shima H, Takeuchi Y, Mishima E, Tanemoto M, Terasaki T, Onogawa T, Unno M, Ito S, Takasawa S, Abe T.  The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides.  Drug Metab Pharmacokinet 25(3):274-282, 2010
15. Mori T, Hitomi H, Nakamichi T, Miyata T, Sato H, Ito S. A novel clinical biomarker for myeloperoxidase-antineutrophil cytoplasmic antibody associated glomerulonephritis. Clin Exp Pharmacol Physiol 37(9):877-878, 2010
16. Tanemoto M, Takeuchi Y, Mishima E, Suzuki T, Abe T, Ito S: Stage of chronic kidney disease is an outcome-predicting factor of angioplasty for atheromatous renal artery stenosis. Hypertens Res 33(11):1206-1210, 2010
17. Ihara G, Kiyomoto H, Kobori H, Nagai Y, Ohashi N, Hitomi H, Nakano D, Pelisch N, Hara T, Mori T, Ito S, Kohno M, Nishiyama A: Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. J Hypertens 28(11): 2289-2298, 2010
18. Ito S: Is renal antiaging possible? Hypertens Res 33(11):1110-1111, 2010
19. Hashimoto J, Ito S. Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery. Hypertension 56(5):926-33, 2010
20. Sugawara A, Uruno A, Kudo M, Matsuda K, Yang CW, Ito S. Effects of PPARγ on hypertension, atherosclerosis, and chronic kidney disease. Endocr J 57(10):847-852, 2010
21. Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R, Ito S. A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial. Nephrol Dial Transplant 25(9):3026-3033, 2010
22. Takahashi K, Shoji I, Shibasaki A, Kato I, Hiraishi K, Yamamoto H, Kaneko K, Murakami O, Morimoto R, Satoh F, Ito S, Totsune K: Presence of Kisspeptin-like Immunoreactivity in Human Adrenal Glands and Adrenal Tumors; J Mol Neurosci 41(1):138-44, 2010
23. Ohtomo S, Izuhara Y, Nangaku M, Dan T, Ito S, van Ypersele de Strihou C, Miyata T: Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat model. J Obes. pii:136502, 2010

- Top | Home -

2009
1. Ito S, Nagasawa T, Abe M, Mori T: Strain Vessel Hypothesis :A viewpoint for linkage of Albuminuria and Carebro-Cardiovascular Risk; Hypertens Res 32; 115-121, 2009
2. Ogihara T, Saruta T, Rakugi H, Shimamoto K, Ito S, Matsuoka H, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Saito I, Shimada K, on behalf of the COLM study investigators: Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients; Hypertens Res 32; 163-167, 2009
3. Tanemoto M, Suzuki T, Abe M, Abe T, Ito S: Physiologic variance of corticotropin affects diagnosis in adrenal vein sampling; Euro J Endocrinol 160; 459-463, 2009
4. Tanemoto M, Suzuki T, Abe M, Abe T, Ito S: Hemodynamic Index of Atheromatous Renal Artery Stenosis for Angioplasty; Clin J Am Soc Nephrol 4; 651-655, 2009
5. Endo S, Mori T, Yoneki Y, Nakamichi T, Hosoya T, Ogawa S, Tokudome G, Hosoya T, Miyata T, Ito S: Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley rats; Hypertens Res 32; 513-519, 2009
6. Jin C, Hu C, Polichnowski A, Mori T, Skelton M, Ito S, Cowley AW Jr.: Effects of Renal Perfusion Pressure on Renal Medullary Hydrogen Peroxide and Nitric Oxide Production; Hypertension 53; 1048-1053, 2009
7. Ishizuka T, Ogawa S, Mori T, Nako K, Nakamichi T, Oka Y, Ito S: Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies; Diabetes Research and Clinical Practice 84; e21-e29, 2009
8. Nakayama M, Kabayama S, Nakano H, Zhu WJ, Terawaki H, Nakayama K, Katoh K, Satoh T, Ito S: Biological effects of electrolyzed water in hemodialysis; Nephron Clin Pract 112; c9-c15, 2009
9. Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, Sun Y, Hosoya T, Kawamata A, Ogawa S, Nakayama M, Miyata T, Ito S: Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats; J Hypertens 27(8); 1664-1671, 2009
10. Ogawa S, Kobori H, Ohashi N, Urushihara M, Nishiyama A, Mori T, Ishizuka T, Nako K, Ito S: Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy; Biomark Insights; 4; 97-102, 2009
11. Ozaki H, Mori K, Nakagawa Y, Hoshikawa S, Ito S, Inoue Y, Takai T, Yoshida K: Autoimmune thyroiditis in Fcgamma receptor-deficient nonobese diabetic mice; Clin Immunol; 132(2):291-293, 2009
12. Mori K, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Yoshida K: Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice? Clin Immunol;130(3):375-377, 2009
13. Mori K, Yoshida K, Mihara M, Ohsugi Y, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S: Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice; Autoimmunity 42(3):228-234, 2009
14. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009); Hypertens Res 32(1):3-107, 2009
15. Hashimoto J, Ito S: Some mechanical aspects of arterial aging: physiological overview based on pulse wave analysis; Ther Adv Cardiovasc Dis 3(5):367-378, 2009
16. Toyohara T, Suzuki T, Morimoto R, Akiyama Y, Souma T, Shiwaku HO, Takeuchi Y, Mishima E, Abe M, Tanemoto M, Masuda S, Kawano H, Maemura K, Nakayama M, Sato H, Mikkaichi T, Yamaguchi H, Fukui S, Fukumoto Y, Shimokawa H, Inui K, Terasaki T, Goto J, Ito S, Hishinuma T, Rubera I, Tauc M, Fujii-Kuriyama Y, Yabuuchi H, Moriyama Y, Soga T, Abe T: SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation; J Am Soc Nephrol 20(12): 2546-2555, 2009
17. Okamura M, Kudo H, Wakabayashi K, Tanaka T, Nonaka A, Uchida A, Tsutsumi S, Sakakibara I, Naito M, Osborne TF, Hamakubo T, Ito S, Aburatani H, Yanagisawa M, Kodama T, Sakai J: COUP-TFII acts downstream of Wnt/b-catenin signal to silence PPARg gene expression and repress adipogenesis; Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5819-24.
18. Wakabayashi K, Okamura M, Tsutsumi S, Nishikawa N, Tanaka T, Sakakibara I, Kitakami J, Ihara S, Hashimoto Y, Hamakubo T, Kodama T, Aburatani H, Sakai J: PPARg/RXRa Heterodimer Targets Gene of Histone Modification Enzyme PR-Setd8 and Regulates Adipogenesis through a Positive Feedback Loop; Mol Cell Biol. 2009 July;29(13):3544-55.
19. Inagaki T, Tachibana M, Magoori K, Kudo H, Tanaka T, Okamura M, Naito M, Kodama T, Shinkai Y, Sakai J: Obesity and Metabolic Syndrome in Histone Demethylase JHDM2a Deficient Mice; Genes to Cells, 2009 Aug;14(8):991-1001.
20. Sakakibara I, Fujino T, Ishii M, Tanaka T, Shimokawa T, Miura S, Zhang W, Tokutake Y, Yamamoto J, Awano M, Iwasaki S, Motoike T, Okamura M, Inagaki T, Kita K, Ezaki O, Naito M, Kuwaki T, Chohnan S, Yamamoto T, Hammer RE, Kodama T, Yanagisawa M, Sakai J: Fasting induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2; Cell Metab. 2009 Feb;9(2):191-202.
21. Mori T, Ito S. Carbonyl stress in hypertension, insulin resistance and chronic kidney disease. IMARS highlights. 2009; 4(1):15.
22. Tanemoto M,. Mishima E., Takeuchi Y. and Abe T: Adrenocorticotropic hormone stimulation during adrenal vein sampling; Hypertension 54: e23, 2009
23. Ohta M, Okuyama R, Ogawa E, Kisu K, Sato H, Aoki M, Aiba S: Cutaneous accumulation of abnormal polyglutamine proteins of patients with dentatorubral-pallidoluysian atrophy; Eur J Neurol, 10: 1468-1331, 2009
24. Hirose T, Mori N, Totsune K, Morimoto R, Maejima T, Kawamura T, Metoki H, Asayama K, Kikuya M, Ohkubo T, Kohzuki M, Takahashi K, Imai Y. Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure. Peptides. ;30(12):2316-22, 2009
25. Takahashi K, Hirose T, Mori N, Morimoto R, Kohzuki M, Imai Y, Totsune K. The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems. Peptides. 2009 Aug;30(8):1575-85
26. Nakamura Y, Hornsby PJ, Casson P, Morimoto R, Satoh F, Xing Y, Kennedy MR, Sasano H, Rainey WE. Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab. 94(6):2192-8, 2009
27. Nakamura M, Miki Y, Akahira J, Morimoto R, Satoh F, Ishidoya S, Arai Y, Suzuki T, Hayashi Y, Sasano H. An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinoma. Endocr Pathol. 2009 Spring;20(1):17-23
28. Okamura M, Inagaki T, Tanaka T and Sakai J: Role of histone methylation and demethylation in adipogenesis and obesity; Organogenesis. 2010, 6(1); 1-9. Review.
29. Miyazawa N, Abe M, Souma T, Tanemoto M, Abe T, Nakayama M Ito S: Methylglyoxal augments intracellular oxidative stress in human aortic endothelial cells; Free Radic Res 44(1); 101-107, 2010
30. Ito S, Nakura N, Le Breton S, Keefe D: Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction; Hypertens Res 33; 62-66, 2010
31. Ito S: Usefulness of RAS inhibition depends on baseline albuminuria; Nature Reviews Nephrology 6; 10-11, 2010
32. Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL Jr, Katayama S, Ito S, Mimran A, Menne J, Rump LC, Januszewicz A, Haller H: Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study; Diabetologia 53; 49-57, 2010
33. Hirose T, Mori N, Totsune K, Morimoto R, Maejima T, Kawamura T, Metoki H, Asayama K, Kikuya M, Ohkubo T, Kohzuki M, Takahashi K, Imai Y. Increased expression of (pro)renin receptor in the remnant kidneys of 5/6 nephrectomized rats. Regul Pept. 159(1-3):93-9, 2010

- Top | Home -

2008
1. Mori K, Yoshida K, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S: Effects of angiotensin 2 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice; Clinical Immunology 126; 97-103, 2008
2. Tanemoto M, Abe T, Ito S: Diagnosis of aldosterone producing adenomas; Kidney Int 73; 362-363, 2008
3. Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Abe M, Uruno A, Ishidoya S, Arai Y, Takahashi K, Sasano H, Ito S: Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas; Endocr J 55(1): 49-55, 2008
4. Ozaki H, Mori K, Nakagawa Y, Hoshikawa S, Ito S, Yoshida K: Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis; Endocr J; 55(1):113-119, 2008
5. Ogawa S, Mori T, Nako K, Ishizuka T, Ito S: Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes; Clin J Am Soc Nephrol 3: 362-368, 2008
6. Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study; Hypertens Res 31: 295-304, 2008
7. Tanemoto M, Toyohara T, Abe T, Ito S: MAGI-1a Functions as a Scaffolding Protein for the Distal Renal Tubular Basolateral K+ Channels; J Biol Chem 283(18): 12241-12247, 2008
8. Tanemoto M, Uruno A, Abe T, Ito S: Hypocalcemia in a patient with severe hypertension and surgically induced relative hypoparathyroidism; J Bone Miner Metab 26: 298-300, 2008
9. Nakayama M, Nakayama K, Zhu WJ, Shirota Y, Terawaki H, Sato T, Kohno M, Ito S: Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: a possible pathological role for enhanced oxidative stress in chronic kidney disease; Nephrol Dial Transplant 23(10); 3096-3102, 2008
10. Shimamoto K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimada K, Tanaka H, Yoshiike N: Impact of Blood Pressure Control on Cardiovascular Events in 26,512 Japanese Hypertensive Patients: The Japan Hypertension Evaluation with AngiotensinⅡ Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study; Hypertens Res 31: 469-478, 2008
11. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S, for the INNOVATION Study Group: Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of the incipient to overt: angiotensin 2 blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study; Hypertens Res 31: 657-664, 2008
12. Tanemoto M, Abe M, Uruno A, Abe T, Ito S: Angiographic index for angioplasty-treatable atheromatous renal artery stenosis; Hypertens Res 31: 881-885, 2008
13. Ogawa S, Mori T, Nako K, Ito S: Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy; Hypertens Res 31: 1147-1155, 2008
14. Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, Morikawa T, Okumura M, Meda I, Kiyomoto H, Hosomi N, Mori T, Ito S, Imanishi M: Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria; J Hypertens 26; 1849-1859, 2008
15. Yamashita K, Okuyama M, Nakagawa R, Honma S, Satoh F, Morimoto R, Ito S, Takahashi M, Numazawa M: Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids; J Chromatogr A 1200; 114-121, 2008
16. Morimoto R, Satoh F, Murakami O, Hirose T, Totsune K, Imai Y, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of adrenomedullin2/ intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues; J Endocrinol 198(1); 175-183, 2008
17. Kasai S, Inui M, Nakamura K, Kakizaki Y, Endo S, Nakamura A, Ito S, Takai T: A novel regulatory role of gp49B on dendritic cells in T-cell priming; Eur J Immunol 38; 2426-2437, 2008
18. Izuhara Y, Sada T, Yanagisawa H, Koike H, Ohtomo S, Dan T, Ito S, Nangaku M, Strihou CY, Miyata T: A novel sartan derivative with very low angiotensin Ⅱ type 1 receptor affinity protects the kidney in type 2 diabetic rats; Arterioscler Thromb Vasc Biol 28(10); 1767-1773, 2008
19. Morimoto R, Satoh F, Murakami O, Totsune K, Saruta M, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of peptide YY in human brain and pituitary tissues; Nutrition 24(9); 878-884, 2008
20. Nakayama K, Nakayama M, Iwabuchi M, Terawaki H, Sato T, Kohno M, Ito S: Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients; Am J Nephrol 28(6): 871-878, 2008
21. Uruno A, Sugawara A, Kudo M, Satoh F, Saito A, Ito S: Stimulatory effects of low-dose 3-Hydroxy-3-Methylglutaryl Coenzyme A reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activates protein kinase; Hypertens Res 31; 2085-2096, 2008
22. Ohtomo S, Nangaku M, Izuhara Y, Yamada N, Dan T, Mori T, Ito S, Strihou CY, Miyata T: The role of megsin, a serin protease inhibitor, in diabetic mesangial matrix accumulation; Kidney Int 74; 768-774, 2008
23. Shimada K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimamoto K, Tanaka H, Yoshiike N: The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study; Hypertens Res 31(10):1903-1911, 2008
24. Suzuki T, Abe T: Thyroid hormone transporters in the brain; Cerebellum. 7(1):75-83.2008
25. Okabe M., Szakács G., Reimers M.A., Suzuki T., Hall M.D., Abe T., Weinstein J.N. and Gottesman M.M.: Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters; Mol. Cancer. Ther. 7: 3081-3091, 2008
26. Fukase K., Ohtsuka H., Onogawa T., Oshio H., Ii T., Mutoh M., Katayose Y., Rikiyama T., Oikawa M., Motoi F., Egawa S., Abe T. and Unno M: Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma; Cancer Sci.99:1785-1792, 2008
27. Oshio H., Abe T., Onogawa T., Ohtsuka H., Sato T., Ii T., Fukase K., Muto M., Katayose Y., Oikawa M., Rikiyama T., Egawa S. and Unno M: Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines; J. Gastroenterol. 43: 538-549, 2008
28. Yamaguchi H., Kobayashi. M, Okada M., Takeuchi T., Unno M., Abe T., Goto J., Hishinuma T. and Mano N: Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes; Cancer Lett. 260:163-169, 2008
29. Ohguchi H, Tanaka T, Uchida A, Magoori K, Kudo H, Kim I, Daigo K, Sakakibara I, Okamura M, Harigae H, Sasaki T, Osborne TF, Gonzalez FJ, Hamakubo T, Kodama T, Sakai J: Hepatocyte nuclear factor 4 alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9; Mol Cell Biol. 2008 Jun;28(12):3917-31.
30. Ohisa N, Yoshida K, Matsuki R, Suzuki H, Miura H, Ohisa Y, Murayama N, Kaku M, Sato H: A comparison of urinary albumin - total protein ratio to phase-contrast microscopic examination of urine sediment for differentiating glomerular and nonglomerular bleeding; Am J Kidney Dis, 52: 235-241, 2008
31. Soma J, Tsuchiya Y, Sakuma T, Sato H: Clinical remission and histopathological resolution of nodular lesions in a patient with γ3 heavy chain deposition disease; Clin Nephrol, 69: 383-386, 2008
32. Joh K, Taguchi T, Shigematsu H, Kobayashi Y, Sato H, Nishi S, Katafuchi R, Nomura S, Fujigaki Y, Utsunomiya Y, Sugiyama H, Saito T, Makino H: Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan; Clin Exp Nephrol, 12: 421-431, 2008
33. Hirose T, Totsune K, Mori N, Morimoto R, Hashimoto M, Nakashige Y, Metoki H, Asayama K, Kikuya M, Ohkubo T, Hashimoto J, Sasano H, Kohzuki M, Takahashi K, Imai Y. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure. Eur J Heart Fail. 2008 Sep;10(9):840-9
34. Nakayama T, Hirose T, Totsune K, Mori N, Maruyama Y, Maejima T, Minagawa K, Morimoto R, Asayama K, Kikuya M, Ohkubo T, Hashimoto J, Kohzuki M, Takahashi K, Imai Y. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure. Peptides. 2008 May;29(5):801-8
35. Matsuura T, Takase K, Ota H, Yamada T, Sato A, Satoh F, Takahashi S. Radiologic anatomy of the right adrenal vein: preliminary experience with MDCT. Am J Roentgenol. 2008; 191(2):402-8.
36. Morimoto R, Satoh F, Murakami O, Totsune K, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K.Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues. Peptides. 2008; 29(5):873-80.
37. Yoshida M, Shimizu N, Suzuki M, Watanabe C, Satoh M, Mori K, Yasutake A: Emergence of methylmercury toxicity long after a perinatal exposure in metallothionein-null and its wild-type C57BL mice strains; Environmental Health Perspectives 116; 746-751, 2008

- Top | Home -

2007
1. Saito A, Sugawara A, Uruno A, Kudo M, Kagechika H, Sato Y, Owada Y, Kondo H, Sato M, Kurabayashi M, Imaizumi M, Tsuchiya S, Ito S: All-trans retinoic in Vitro angiogenesis via retinoic acid receptor: Possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling; Endocrinology 148(3); 1412-1423, 2007
2. Nakagawa Y, Mori K, Hoshikawa S, Ozaki H, Ito S, Yoshida K: Development of Subclinical Hyperthyroidism due to Graves' Disease in a Hypothyroid Woman who had Undergone Hemithyroidectomy for Adenomatous Goiter and Radiotherapy for Nasopharyngeal Cancer: Endocrine Journal 54(1); 35-37, 2007
3. Ogawa S, Takeuchi K, Mori T, Nako K, Ishizuka T, Ito S: Effect of increasing dose or combination of an initially recommended dose of angiotensin-converting enzyme inhibitors and angiotensin type-1 receptor blockers in suppression of diabetic nephropathy: a comparative study; Hypertension Res 30; 325-334, 2007
4. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease; Clin Exp Nephrol 11; 41-50, 2007
5. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease (CKD) in Japanese general population predicted by MDRD equation modified by a Japanese coefficient; Clin Exp Nephrol 11; 156-163, 2007
6. Tanemoto M, Satoh F, Abe T, Ito S: To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not ?; J Hypertens 25(2); 480-481, 2007
7. Tanemoto M, Abe M, Satoh F, Abe T, Satoh H, Ito S: Mesangial proliferative glomerulonephritis with aldosterone-producing adenoma; Clin Exp Nephrol 11; 164-167, 2007
8. Mori K, Yoshida K, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Watanabe C: Methylmercury inhibition of type Ⅱ 5'-deiodinase activity resulting in a decrease in growth hormone production in GH3 cells; Toxicology 237; 203-209, 2007
9. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S, INNOVATION Study Group: Prevention of transition from incipient to overt nephrology with telmisartan in patients with type 2 diabetes; Diabetes Care 30(6); 1577-1578, 2007
10. Tanemoto M, Satoh F, Abe T, Ito S: To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not?-round 2; J Hypertens 25(7); 1517-1518, 2007
11. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totsune K, Hoshi H, Ito S, Imai Y: Kidney dysfunction as a risk factor for symptomatic stroke events in a general Japanese population- the Ohasama study; Nephrol Dial Transplant 22; 1910-1915, 2007
12. Nakayama M, Saito K, Sato E, Nakayama K, Terawaki H, Ito S, Kohno M: Radical generation by the non-enzymatic reaction of methylglyoxal and hydrogen peroxide; Redox Report 12(3); 125-133, 2007
13. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Yoshida K: Intrathyroidal persistence of human parvirus B19 DNA in a patients with Hashimoto's thyroiditis; J Infect 55; e29-e31, 2007
14. Vanbelleghem H, Vanholder R, Levin NW, Becker G, Craig JC, Ito S, Lau J, Locatelli F, Zoccali C, Solez K, Hales M, Lameire N, Eknoyan G; The Kidney Disease: Improving Global Outcomes website: Comparison of guidelines as a tool for harmonization; Kidney Int 71; 1054-1061, 2007
15. Tanemoto M, Takase K, Yamada T, Satoh A, Abe T, Ito S: Dilation of Renal Artery Stenosis after Administration of Losartan; Hypertens Res 30; 999-1002, 2007
16. Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Design and Baseline Characteristics of and Observational Study in Japanese Patients with Hypertension: Japan Hypertension Evaluation with Angiotensin Ⅱ Antagonist Losartan Therapy (J-HEALTH); Hypertens Res 30; 807-814, 2007
17. Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S: Localization of Aldosterone-Producing Adrenocortical Adenomas: Significance of Adrenal Venous Sampling; Hypertens Res 30(11); 1083-1095, 2007
18. Nakayama M, Kabayama S, Terawaki H, Nakayama K, Kato K, Sato T, Ito S: Less oxidative hemodialysis sodium rendered by cathode-side application of electrolyzed water; Hemodialysis Int 11; 322-327, 2007
19. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S: Reduction of serum antioxidative capacity during hemodialysis; Clin Exp Nephrol 11; 218-224, 2007
20. Morimoto R, Satoh F, Murakami O, Totsune K, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of adrenomedullin2/intermedin in human brain, heart, and kidney; Peptide 28; 1095-1103, 2007
21. Morimoto R, Satoh F, Murakami O, Totsune K, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K: Immunolocalization of urotensin Ⅱ and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues; Peptide 29; 873-880, 2007
22. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan; Am J Kidney Dis 50; 927-937, 2007

- Top | Home -

2006
1. Ito O, Nakamura Y, Tan L, Ishizuka T, Sasaki Y, Minami N, Kanazawa M, Ito S, Sasano H, Kohzuki M: Expression of cytochrome P-450 4 enzymes in the kidney and liver: Regulation by PPAR and species-difference between rat and human; Mol Cell Biochem 284; 141-148, 2006
2. Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL Jr., Januszewicz A: Preventing microalbuminuria in patients with diabetes: rationale and design of the randomized olmesartan and diabetes microalbuminuria prevention (ROADMAP) study; J Hypertens 24; 403-408, 2006
3. Mori K, Yoshida K, Tani J, Hoshikawa S, Ito S, Watanabe C: Methylmercury inhibits type Ⅱ 5'-deiodinase activity in NB41A3 neuroblastoma cells; Toxicology Letters 161; 96-101, 2006
4. Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S: Angiotensin Ⅱ type-1 receptors blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy; Hypertension 47; 699‐705,2006
5. Ogawa S, Takeuchi K, Mori T, Nako K, Ito S: Spironolactone further reduced urinary albumin excretion and plasma b-type natriuretic peptide levels in hypertensive type Ⅱ diabetes treated with angiotensin-converting enzyme inhibitor: Clin Exp Pharmacol Physiol 33; 477-479, 2006
6. Imai E, Ito S, Haneda M, Chan JCN, Makino H, for the ORIENT Investigators: Olmesartan reducing incidence of endstage renal disease in diabetic nephropathy trial (ORIENT): Rationale and study design; Hypertens Res 29; 703-709, 2006
7. Mori K, Yoshida K, Hoshikawa S, Ito S, Yoshida M, Satoh M, Watanabe C: Effects of perinatal exposure to low doses of cadmium or methylmercury on thyroid hormone metabolism in metallothionein-deficient mouse neonates; Toxicology 228; 77-84, 2006
8. Mori T, Cowley AW, Ito S: Molecular mechanisms and therapeutic strategies of chronic renal injury: Physiological role of angiotensin Ⅱ-induced oxidative stress in renal medulla; J Pharmacol Sci 100; 2-8, 2006
9. Tanemoto M, Honkura K, Abe M, Satoh F, Abe T, Ito S: Aldosterone-producing adenoma accompanied with renal artery stenosis; J Nephrol 19; 540-542, 2006
10. Nakamura Y, Suzuki S, Suzuki T, Ono K, Miura I, Satoh F, Moriya T, Saito H, Yamada S, Ito S, Sasano H: MDM2: A Novel Mineralocorticoid-Responsive Gene Involved in Aldosterone-Induced Human Vascular Structural Remodeling; Am J Pathol 169; 362-371, 2006

- Top | Home -

2005
1. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S: The telmisartan renoprotective study from incipient nephropathy to overt nephropathy- rationale, study design, treatment plan and baseline characteristics of the incipient to overt: Angiotensin Ⅱ receptor blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study; J Int Med Res 33; 677-686, 2005
2. Chung BH, Li C, Sun BK, Lim SW, Ahn KO, Yang JH, Choi YH, Yoon KH, Sugawara A, Ito S, Kim J, Yang CW: Rosiglitazone Protects Against Cyclosporine-Induced Pancreatic and Renal Injury in Rats; Am J Transplant 5; 1856-1867, 2005
3. Mori K, Yoshida K, Kikuchi T, Sakakibara T, Hisata O, Nukiwa T, Moriya T, Tani J, Hoshikawa S, Ito S: Thyroid Metastasis of Pulmonary Adenocarcinoma; THYROID 15(2); 176-177, 2005
18. Tanemoto M, Abe T, Satoh F, Ito S: Plasma Renin Activity Revealed Renal Artery Stenosis Concealed by Aneurysms; UROLOGY 65; 592. e29-592.e31; 2005
4. Tanemoto M, Abe T, Satoh F, Ito S: Bilateral calcified renal artery aneurysms in a patient with von Recklinghausen's disease; Nephrol Dial Transplant 20; 1007-1008, 2005
5. Tanemoto M, Saito H, Satoh F, Satoh H, Abe T, Ito S; Predictors of Undiagnosed Renal Artery Stenosis among Japanese Patients with Risk Factors of Atherosclerosis; Hypertens Res 28; 237-242, 2005
6. Tanemoto M, Abe T, Chaki T, Satoh F, Ishibashi T, Ito S: Cutting balloon angioplasty of resistant renal artery stenosis caused by fibromuscular dysplasia; J Vasc Surg 41; 898-901, 2005
7. Uruno A, Sugawara A, Kanatsuka H, Kagechika H, Saito A, Sato K, Kudo M, Takeuchi K, Ito S: Up-Regulation of Nitric Oxide Production in Vascular Endothelial Cells by All-trans Retinoic Acid through the Phosphoinositide 3-Kinase/Akt Pathway; Circulation 112(5); 727-736, 2005
8. Hoshikawa S, Mori K, Tani J, Jin Z, Nakagawa Y, Satoh J, Ito S, Yoshida K: Spontaneous lymphocytic thyroiditis in interferon regulatory factor-1 deficient non-obese diabetic mice; J Endocrinol Invest 28; 340-345, 2005
9. Tanemoto M, Abe T, Ito S: PDZ-Binding and Di-Hydrophobic Motifs Regulate Distribution of Kir4.1 Channels in Renal Cells; J Am Soc Nephrol 16; 2608-2614, 2005
10. Chung BH, Lim SW, Ahn KO, Sugawara A, Ito S, Choi BS, Kim YS, Bang BK, Yang CW: Protective effect of peroxisome proliferators activated receptor gamma agonists on diabetic and non-diabetic renal diseases; Nephrology 10; S40-S43, 2005
11. Tanemoto M, Ito S: Reply; J Vasc Surg 42(5); 1039-1040, 2005
12. Mori K, Yoshida K, Komatsu A, Tani J, Nakagawa Y, Hoshikawa S, Ito S: Autoinduction of tumor necrosis factor-α in FRTL-5 rat thyroid cells; J Endocrinol 187; 17-24, 2005
13. Sarkis A, Ito O, Mori T, Kohzuki M, Ito S, Verbalis J, Cowley AW, Roman RJ: Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetic insipidus; Am J Physiol Renal Physiol 289; F1333-F1340, 2005
14. Tanemoto M, Abe M, Satoh F, Abe T, Ito S: Renal Artery Dissection after Angiographic Evaluation of Lower Extremities; Hypertens Res 28; 853-855, 2005
15. Kazama I, Matsubara M, Ejima Y, Michimata M, Suzuki M, Miyama N, Sato A, Sato H, Ito S: Steroid resistance in prolonged type Ⅰ membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal; Clin Exp Nephrol 9; 62-68, 2005
16. Okabe M, Unno M, Harigae H, Kaku M, Okitsu Y, Sasaki T, Mizoi T, Shiiba K, Takanaga H, Terasaki T, Matsuno S, Sasaki I, Ito S, Abe T: Characterization of the organic cation transporter SLC22A16: A doxorubicin importer; Biochem Bioph Res Co 333; 754-762, 2005

- Top | Home -

2004
1. Arima S,Kohagura K,Hong-Lan Xu,Sugawara A,Uruno A,Satoh F,Takeuchi K,Ito S:Endothelium-Derived Nitric Oxide Modulates Vascular Action of Aldosterone in Renal Arteriole. Hypertension 43: 352‐357, 2004.
2. Mikkaichi T, Suzuki T, Onogawa T, Tanemoto M, Mizutamari H, Okada M, Chaki T, Matuda S, Tokui T, Eto N, Abe M, Satoh F, Unno M, Hishinuma T, Inui K, Ito S, Goto J, Abe T: Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney; Proc Natl Acad Sci USA Vol.101 No.10; 3569-3574, 2004.
3. Hoshikawa S, Mori K, Kaise N, Nakagawa Y, Ito S, Yoshida K: Artifactually Elevated Serum-Free Thyroxine Levels Measured by Equilibrium Dialysis in a Pregnant Woman with Familial Dysalbuminemic Hyperthyroxinemia; THYROID Vol.14 No.2; 155-160, 2004.
4. Yamamoto J, Ikeda Y, Iguchi H, Fujino T, Tanaka T, Asaba H, Iwasaki S, Ioka RX, Kaneko IW, Magoori K, Takahashi S, Mori T, Sakaue H, Kodama T, Yanagisawa M, Yamamoto TT, Ito S, Sakai: A Kruppel-like factor KLF15 Contributes Fasting-induced Transcriptional Activation of Mitochondrial Acetyl-CoA Synthetase Gene AceCS2: J Biol Chem 279(17); 16954-16962, 2004.
5. Mikkaichi T, Suzuki T, Tanemoto M, Ito S, Abe T: The Organic Anion Transporter (OATP) Family; Drug Metabol. Pharmacokin. Vol.19No.3: 171-179, 2004.
6. Sato K, Sugawara A, Kudo M, Uruno A, Ito S, Takeuchi K: Expression of peroxisome proliferators-activated receptor isoform proteins in the rat kidney; Hypertens Res 27; 417-425, 2004.
7. Ogawa S, Takeuchi K, Ito S: Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes; Diabetes, Obesity and Metabolism 6; 384-390, 2004.
8. Jin Z, Mori K, Fujimori K, Hoshikawa S, Tani J, Satoh J, Ito S, Satomi S, Yoshida K: Experimental autoimmune thyroiditis in nonbese diabetic mice lacking interferon regulatory factor-1; Clinical Immunology 113; 187-192, 2004.
9. Kudo M, Sugawara A, Uruno A, Takeuchi K, Ito S: Transcription Suppression of Peroxisome Proliferator-Activated Receptor γ2 Gene Expression by Tumor Necrosis Factor α via an Inhibition of CCAAT/Enhancer-binding Protein δ during the Early Stage of Adipocyte Differentiation; Endocrinology 145(11); 4948-4956, 2004.
9. Tanemoto M, Abe T, Onogawa T, Ito S: PDZ binding motif-dependent localization of K+ on the basolateral side in distal tubules; Am J Physiol Renal Physiol 287; F1148-F1153, 2004.
10. Kazama I, Matsubara M, Michimata M, Suzuki M, Hatano R, Sato H, Ito S: Adult onset Fanconi syndrome: extensive tobulointerstitial lesions an glomerulopathy in the early stage of Chinese herbs nephropathy; Clin Exp Nephrol. 8(3); 283-287, 2004.
11. Totsune K, Takahashi K, Arihara Z, Sone M, Murakami O, Ito S, Kikuya M, Ohkubo T, Hashimoto J, Imai Y: Elevated plasma levels of immunoreactive urotensinⅡ and its increase urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy; Peptides. 25(10); 1809-1814, 2004.
12. Arima S, Ito S: Role of renal eicosanoids in the control of intraglomerular and systemic blood pressure during development of hypertension; Contrib Nephrol. 143; 65-76, 2004.
13. Uruno A, Sugawara A, Kanatsuka H, Arima S, Taniyama Y, Kudo M, Takeuchi K, Ito S: Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possible by mitogen-activated protein kinase kinase in vascular endothelial cells; Hypertens Res 27; 887-895, 2004
14. Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y: Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis; J Lab Clin Med 143; 106-114, 2004

- Top | Home -

2003
1. Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Murakami O:Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci 104: 1-5, 2003.
2. Michimata M, Kazama I, Mizukami K, Araki T, Nakamura Y, Suzuki M, Wang W, Fujimori K, Satomi S, Ito S, Imai Y, Matsubara M: Urinary concentration defect and limited expression of sodium cotransporter, rBSC1, in a rat model of chronic renal failure. Nephron Physiol 93: 34-41, 2003.
3. Ito O, Hasegawa Y, Sato K, Mitsui H, Yuda F, Sato H, Ito S, Kudo K: A Case of Exercise-Induced Acute Renal Failure in a Patient with Idiopathic Renal Hypouricemia Developed during Antihypertensive Therapy with Losartan and Trichlormethiazide. Hypertens Res 26: 509-513, 2003.
4. Sato Y, Suzuki T, Hidaka K, Sato H, Ito K, Ito S, Sasano H:
5. Ogawa S, Takeuchi K, Ito S: Plasma BNP Levels in the Treatment of Type 2 Diabetes with Pioglitazone. J Clin Endocrinol Metab 88(8): 3993-3996, 2003.
6. Mao Y, Ootaka T, Saito T, Sato H, Sato T, Ito S: The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells. Clin Exp Nephrol 7: 201-209, 2003.
7. Tanemoto M,Abe T,Obara N,Abe M,Satoh F,Ito S: Successful Treatment of Severe Hypertension with the Combination of Angiotensin Converting Enzyme Inhibitor and Angiotensin Ⅱ Receptor Blocker. Hypertens Res 26: 863-868, 2003.
8. Ishizuka T, Ito O, Tan L, Ogawa S, Kohzuki M, Omata K, Takeuchi K, Ito S:Regulation of Cytochrome P-450 4A Activity by Peroxisome Proliferator-Activated Receptors in the Rat Kidney.Hypertens Res 26:929-936,2003.
9. Arima S,Ito S:The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy.Nephrol Dial Transplant 18:1966-1969,2003.
10. Arima S,Kohagura K,Xu H,Sugawara A,Abe T,Satoh F,Takeuchi K,Ito S:Nongenomic Vascular Action of Aldosterone in the Glomerular Microcirculation.J Am Soc Nephrol 14:2255-2263,2003.
11. Sugawara A,Takeuchi K,Uruno A,Kudo M,Sato K, Ito S:Effects of Mitogen-Activated Protein Kinase Pathway and Co-Activator CREP-Binding Protein on Peroxisome Proliferator-Activated Receptor-γ-Mediated Transcription Suppression of Angiotensin Ⅱ Type 1 Receptor Gene.Hypertens Res vol.26 No.8 p623-628,2003.
12. Sugawara A,Takeuchi K,Suzuki T,Ito K,Sasano H, Ito S:A Case of Aldosterone-Producing Adrenocortical Adenoma Associated with a Probable Post- Operative Adrenal Crisis: Histopathological Analyses of the Adrenal Gland.Hypertens Res vol.26 No.8 p663-668,2003.
13. Uruno A,Sugawara A,Kudo M,Sato M,Sato K,Ito S,Takeuchi K:Transcription Suppression of Thromboxane Receptor Gene Expression by Retinoids in Vascular Smooth Muscle Cells.Hypertens Res vol.26 No.10 p815-821,2003.
14. Abe M,Mori K,Nagai K,Ito S:Relapse of Graves'Disease in a Patient with Pheochromocytoma.Endocrine J,50(6): 767-770,2003.
15. Tanaka T,Yamamoto J,Iwasaki S,Asaba H,Hamura H,Ikeda Y,Watanabe M,Magoori K,Ioka RX,Tachibana K,Watanabe Y,Uchiyama Y,Sumi K,Iguchi H,Ito S,Doi T,Hamakubo T,Naito M,Auwerx J,Yanagisawa M,Kodama T,Sakai J:Activation of peroxisome proliferators-activated receptor δ induces fatty acid β‐oxidation in skeletal musce and attenuates metabolic syndrome.Proc Natl Acad Sci USA; 100(26): 15924-9,2003.
16. Nakai S,Sugitani Y,Sato H,Ito S,Miura Y,Ogawa M,Nishi M,Jishage K,Minowa O,Noda T:Crucial roles of Brn1 in distal tubule formation and function in mouse kidney.Development 130; 4751‐4759,2003.
17. Adachi H, Suzuki T, Abe M, Asano N, Mizutamari H, Tanemoto M, Nishio T, Onogawa T, Toyohara T, Kasai S, Satoh F, Suzuki M, Tokui T, Unno M, Shimosegawa T, Matsuno S, Ito S, Abe T: Molecular characterization of human and rat organic anion transporter OATP-D; Am J Physiol Renal Physiol 285: 1188-1197, 2003.
18. Suzuki T, Onogawa T, Asano N, Mizutamari H, Mikkaichi T, Tanemoto M, Abe M, Satoh F, Unno M, Nunoki K, Suzuki M, Hishinuma T, Goto J, Shimosegawa T, Matsuno S, Ito S, Abe T; Identification and Characterization of Novel Rat and Human Gonad-Specific Organic Anion Transporters; Molecular Endocrinology 17; 1203-1215, 2003.
19. Munakata M, Aihara A, Nunokawa T, Ito N, Imai Y, Ito S, Yoshinaga K: The influence of one-year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension- comparison with calcium channel blocker; Clinical and Experimental Hypertension Vol.25No.3; 169-181, 2003.

- Top | Home -

2002
1. Ren Y, Arima S, Carretero OA, Ito S: Possible role of adenosine in macula  densa control of glomerular hemodynamics. Kidney Int 61: 169-176, 2002.
2. Sugawara A, Uruno A, Kudo M, Ikeda Y, Sato K, Taniyama Y, Ito S, Takeuchi K: Transcription suppression of thromboxane receptor gene by peroxisome proliferators - activated receptor - γvia an interaction with Sp1 in vascular smooth muscle cells. J Biol Chem 277: 9676-9683, 2002.
3. Ohtaka A, Ootaka T, Sato H, Soma J, Sato T, Saito T, Ito S: Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis. Am J Kidney Dis 39: 475-485, 2002.
4. Matsubara M, Nogae S, Ito S: Novel trial for the treatment of steroid dependency in minimal change disease: Combined therapy of camostat mesilate and glycyrrhizin. Nephron 90: 357-360, 2002.
5. Sato K, Ohsaga A, Oshiro T, Ito S, Maruyama Y: Involvement of GTP-binding protein in pancreatic cAMP-mediated exocytosis. Pflugers Arch 443: 394-398, 2002.
6. Arima S, Kohagura K, Takeuchi K, Taniyama Y, Sugawara A, Ikeda Y, Abe M, Omata K, Ito S: Biphasic vasodilator action of troglitazone on the renal microcirculation. J Am Soc Nephrol 13: 342-349, 2002.
7. Takahashi N, Brooks HL, Wade JB, Liu W, Kondo Y, Ito S, Knepper MA, Smithies O: Posttranscriptional compensation for heterozygous disruption of the kidney-specific NaK2Cl cotransporter gene. J Am Soc Nephrol 13: 604-610, 2002.
8. Jin S, Ootaka T, Soma J, Sato T, Sato H, Ito S, Saito T: Role of B2 integrins in glomerular leucocytes in Henoch-Schoenlein purpura nephritis: An age-matched comparative study with immunoglobulin a nephropathy. Nephrology 7; 189-197, 2002.
9. Abe T, Suzuki T, Unno M, Tokui T, Ito S: Thyroid hormone transporters: recent advances. Trends Endocrinol Metab 13: 215-20, 2002.
10. Nakagawa Y, Mori K, Hoshikawa S, Yamamoto M, Ito S, Yoshida K: Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. Clin Endocrinol 57: 467-471, 2002.
11. Tani J, Mori K, Hoshikawa S, Nakazato T, Satoh J, Nakagawa Y, Ito S, Yoshida K: Prevention of lymphocytic thyroiditis in iodide-treated non-obese diabetic mice lacking interferon regulatory factor-1. Eur J Endocrinol 147: 809-814, 2002.
12. Nogae S, Michimata M, Araki T, Suzuki M, Kazama I, Ito S, Imai Y, Matsubara M: Detection of mRNA for Alpha-3 chain of type IV collagen in the glomerular epithelium, and the effect of perfused elastase on its expression. Nephron 92: 853-859, 2002.
13. Ohtaka A, OotakaT, Sato H, Ito S: Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm? Nephrol Dial Transplant 17 Suppl 9: 11-5, 2002.

- Top | Home -

2001
1. Wang J, Konda R, Sato H, Sakai K, Ito S, Orikasa S.: Clinical significance of urinary interleukin-6 in children with reflux nephropathy. J Urol 165: 210-214, 2001.
2. Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Mouri T: Immunoreactive orexin-A in human plasma. Peptides 22: 139-142, 2001.
3. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, Ito S, Sato H, Hisamichi S, Imai Y: Factors affecting the difference between screening and home blood pressure measurements: The Ohasama Study. J Hypertens 19: 13-19, 2001.
4. Ito O, Omata K, Ito S, Hoagland K, Roman R: Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid. Am J Physiol Regulatory Integrative Comp Physiol 280: R822-R830, 2001.
5. Taniyama Y, Sato K, Sugawara A, Uruno A, Ikeda Y, Kudo M, Ito S, Takeuchi K: Renal tubule-specific transcription and chromosomal localization of rat thiazide-sensitive Na-Cl cotransporter gene. J Biol Chem 276: 26260-26268, 2001.
6. Fujiwara K, Adachi H, Nishino T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T, Asano N, Tanemoto M, Seki M, Shiiba K, Suzuki M, Kondo Y, Nunoki K, Shimosegawa T, Iinuma K, Ito S, Matsuno S, Abe T: Indentification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 142: 2005-2012, 2001.
7. Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo K, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: Lst-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120: 1689-1699, 2001.
8. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S: Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes. Hypertens Res 24: 229-233, 2001.
9. Michimata M, Wang W, Fujita S, Mizutani H, Fujimori K, Satomi S, Ohta M, Ito S, Kimura T, Araki T, Imai Y, Sakai J: Limited urinary concentration and damaged tubules in rats with a syngeneic kidney graft. Kidney Int 60: 672-679, 2001.
10. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S: Transcriptional suppression of type 1 angiotensin ii receptor gene expression by peroxisome proliferator-activated receptor- gamma vascular smooth muscle cells. Endocrinology 142: 3125-3134, 2001.
11. Ikeda Y, Yamamoto J, Okamura M, Fujino T, Takahashi S, Takeuchi K, Osborne TF, Yamamoto TT, Ito S, Sakai J: Transcriptional regulation of the murine acetyl CoA synthetase 1 gene through multiple clustered binding sites for SREBPs and a single neighboring site for Sp1. J Biol Chem 276: 34259-34269, 2001.
12. Arima S, Kohagura K, Abe M, Ito S: Mechanisms that control glomerular hemodynamics. Clin Exp Nephrol 5: 55-61, 2001.
13. Kohagura K, Arima S, Endo Y, Chiba Y, Ito O, Abe M, Omata K, Ito S: Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles. Hypertens Res 24: 551-557, 2001.
14. Totsune K, Takahashi K, Aihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H, Murakami O: Role of urotensin II in patients on dialysis. Lancet 358 : 810‐811, 2001.
15. Konda R, Sato H, Ito S, Sakai K, Kimura N and Nagura H: Renin containing cells are present predominantly in scarred areas but not in multicystic dysplastic kidney. J Urol 166: 1910‐1914, 2001.
16. Ren YL, Garvin JL, Ito S, Carretero OA: Role of neuronal nitric oxide     synthase in the macula densa. Kidney Int 60: 1676-1683, 2001.
17. Arima S and Ito S : New insights into actions of the renin-Angiotensin system in the kidney : Concentrating on the Ang Ⅱ receptors and the newly described Ang‐(1‐7) and its receptor. Seminars in Nephrology 21 : 535-543,2001.
18. Mori K, Yoshida K, Tani J, Nakagawa Y, Hoshikawa S, Ito S: Double-stranded RNA-induced interferon regulatory factor-1 gene expression in FRTL-5 rat thyroid cells. Mol Cell Endocrinol 184: 77-86, 2001.
19. Totsune K, Takahashi K, Mackenzie HS, Arihara Z, Satoh F, Sone M, Murakami O, Ito S, Brenner BM, Mouri T :Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal ablation: decreased expression of calcitonin receptor-like receptor and receptor‐activity modifying protein‐3.Peptides 22 : 1933‐1937,2001.
20. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T, Suzuki M, Kondo Y, Nunoki K, Shimosegawa T, Iinuma K, Ito S, Matsuno S, Abe T: Identification of thyroid hormone transporters in humans: Different molecules are involved in a tissue-specific manner; Endocrinology Vol.142No.5; 2005-2012, 2001

- Top | Home -

2000
1. Kurihara I, Soma J, Sato H, Ikarashi T, Tsunoda K, Miura R, Suzuki T, Sato M, Furuyama T, Ito S, Saito T: A case of exercise-induced acute renal failure in patients with enhanced renal hypouricaemia. Nephrol Dial Transplant 15: 104-106, 2000.
2. Michimata M, Nogae S, Ohta M, Kaizuma S, Imai Y, Ito S, Matsubara M: Topographic distribution of aquaporin 2 mRNA in the kidney of dehydrated rats. Exp Nephrol 8: 28-36, 2000.
3. Saito T, Ootaka T, Sato H, Soma J, Sato T, Ito S: Do proteinuria and hypertension at biopsy influence long-term outcome of IgA nephropathy? Nephrology (suppl. 5): A12, 2000.
4. Abe M, Nata K, Shervani N, Kobayashi S, Tomioka-Kumagai T, Ito S, Takasawa S, Okamoto H: Identification of a novel Reg family gene, Reg IIIδ, and mapping of all three types of Reg family genes in a 75-kilobase mouse genomic region. Gene 246: 111-122, 2000.
5. Noshiro T, Shimizu K, Watanabe T, Akama H, Shibukawa S, Miura W, Ito S, Miura Y: Change in clinical features and long-term prognosis in patients with pheochromocytoma: Am J Hypertension 13: 35-43, 2000.
6. Kasai Y, Kyogoku S, Shima N, Omata K, Ito S, Imai Y, Abe K: The use of new approach by a cubic curve fitting method to calculate the trough/peak ratios for manidipine hydrochloride in hypertensives: Therap Res 21: 633-643, 2000.
7. Ogawa S, Takeuchi K, Sugimura K, Fukuda M, Lee R, Ito S, Sato T: Bezafibrate Reduces Blood Glucose in Type 2 Diabetes Mellitus: Metabolism 49(3): 331-334, 2000.
8. Nogae S, Michimata M, Kanazawa M, Honda S, Ohta M, Imai Y, Ito S, Matsubara M: Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle: Nephron 57: 2055-2063, 2000.
9. Soma J, Saito T, Taguma Y, Chiba S, Saito H, Sugimura K, Ogawa S, Ito S: High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 11: 690-9, 2000.
10. Nogae S, Michimata M, Kanazawa M, Honda S, Ohta M, Imai Y, Ito S, Matsubara M: Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle. Kidney Int 57: 2055-63, 2000.
11. Arima S, Ito S: Angiotensin II type 2 receptors in the kidney: evidence for endothelial-cell-mediated renal vasodilatation: Nephrol Dial Transplant 15: 448-451, 2000.
12. Kohagura K, Endo Y, Ito O, Arima S, Omata K, Ito S: Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arterioles. Acta Physiol Scand 168: 107-112, 2000.
13. Ishidoya S, Fukuzaki A, Kaneto H, Takeda A, Ogata Y, Sasaki T, Suzuki K, Watanabe R, Hoshi S, Kikuya M, Takeuchi K, Ito S, Orikasa S: Chronic unilateral ureteral obstruction represented as renin-dependent hypertension. Nephron 85: 175-177, 2000.
14. Ito S: Control of afferent and efferent arteriolar tone. Advances in Organ Biology 9: 63-74, 2000.
15. Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Hayashi Y, Sasano H, Mouri T: Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 21; 565-570, 2000.
16. Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji Y, Ito S, Sato H, Hisamichi S, Imai Y: Prediction of stroke by ambulatory blood pressure montitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 18: 847-854, 2000.
17. Matsubara M, Ohkubo T, Michimata M, Hozawa A, Ishikawa K, Katsuya T, Nagai K, Tsuji I, Higaki J, Araki T, Satoh H, Hisamichi S, Ito S, Ogihara T, Imai Y: Japanese individual do not harbor the T594M mutation but do have the T592S mutation in the C-terminus of the beta-subunit of the epithelial sodium channel: the Ohasama study. J Hypertens 18: 861-6, 2000.
18. Arima S, Ito S: Isolated juxtaglomerular apparatus as a tool for exploring glomerular hemodynamics: Application of microperfusion techniques. Exp Nephrol 8: 304-311, 2000.
19. Nishio T, Adachi H, Nakagomi R, Tokui T, Sato E, Tanemoto M, Fujiwara K, Okabe M, Onogawa T, Suzuki T, Nakai D, Shiiba K, Suzuki M, Ohtani H, Kondo Y, Unno M, Iinuma K, Nunoki K, Matsuno S, Abe T、Ito S,: Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate. Biochem Biophys Res Commun 7: 831-8, 2000.
20. Soma J, Ootaka T, Sato H, Ito S, Sato T: Tubulointerstitial changes are less important in membranoproliferative glomerulonephritis than in IgA nephropathy. Nephron 86: 230-1, 2000.
21. Suzuki N, Hishinuma T, Abe F, Omata K, Ito S, Sugiyama M, Mizugaki M : Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. Prostaglandins Other Lipid Mediat 62: 395-403, 2000.
22. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Y. Imai: Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36: 901-6, 2000.
23. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y; Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch Intern Med 160: 3301-6, 2000.
24. Totsune K, Takahashi K, Mackenzie HS, Murakami O, Arihara Z, Sone M, Mouri T, Brenner BM, Ito S: Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP) 2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. Clin Sci (Colch) 99: 541-546, 2000.
25. Ikeda Y, Sugawara A, Taniyama Y, Uruno A, Igarashi K, Arimura S, Ito S, Takeuchi K: Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor γin macrophages via an interaction with NRF2. J BiolChem 275: 33142-33150, 2000.
26. Ito S: Glomerular hemodynamics and hypertension. Kidney and Hypertension; 42-53, 2000.(14th Niigata Symposium of Nephrology)

- Top | Home -